タンパク質複合体の計算機予測に関する研究 by QU, Liang & 瞿, 良
  
 
タンパク質複合体の計算機予測に関する研究 
 
Computational Prediction of Protein Complex Structure 
 
 
 
 
 
 
 
 
 
 
 
 
2019年 
千葉大学大学院 医学薬学府 
薬品物理化学研究室 
瞿  良 
 
 
  
 I 
CONTENT 
Chapter I: Computational Prediction of Protein Complex Structure ····················· 1 
I-Abstract ······························································································ 2 
I-1. Introduction ······················································································ 3 
I-2. Methods ··························································································· 6 
I-2.1 Selecting protein ··············································································· 6 
I-2.2 Docking ·························································································· 6 
I-2.3 Score ······························································································ 7 
I-2.4 Statistics ························································································· 8 
I-3. Results ··························································································· 16 
I-3.1 Orientation score ············································································· 16 
I-3.1.1 MMP-1 ······················································································· 22 
I-3.1.2HIV-1 integrase ············································································· 22 
I-3.1.3 HLA ·························································································· 30 
I-3.1.4 HIV-1 protease ············································································· 40 
I-3.1.5 HIV-1 reverse transcriptase ····························································· 49 
I-3.1.6 Fab domain ················································································· 55 
I-3.2 Adjusting score based on the secondary structure ···································· 60 
I-4. Discussion ······················································································· 70 
I-4.1 Reducing Orientation calculation ························································· 70 
I-4.2 Water molecules ·············································································· 71 
I-4.3 Morse potential ··············································································· 73 
I-4.4 Optimizations of Orientation ······························································ 75 
I-4.5 About the result of HIV-1 reverse transcriptase ······································ 77 
I-4.6 About CDR of Fab domain ································································ 82 
I-4.7 About the result of Fab domain ··························································· 85 
I-5. Conclusion ······················································································ 87 
 
Chapter II: Computational Study on the Assembly of Amyloid β-Peptides in the 
Hydrophobic Environment ······································································· 88 
II-Abstract ··························································································· 89 
II-1. Introduction ··················································································· 90 
II-2. Methods ························································································ 93 
II-2.1 Construction of calculation models ····················································· 93 
II-2.2 Computational condition for MD simulation ········································· 93 
 II 
II-2.3 Analysis of simulation results ···························································· 94 
II-3. Results ·························································································· 96 
II-3.1 Conformations of Aβ42 peptides in the low-polarity solution ····················· 96 
II-3.2 Extended simulation of six Aβ42 peptides ············································ 100 
II-3.3 Surface area of the Aβ complex and inter-molecular hydrogen bonding ······ 107 
II-4. Discussion ····················································································· 111 
II-4.1 Secondary structure of Aβ peptides ··················································· 111 
II-4.2 Structural diversity of Aβ peptides in simulation ··································· 114 
II-4.3 Comparison with the previous calculation studies ································· 116 
II-5. Conclusion ···················································································· 118 
Acknowledgment ·················································································· 119 
References ·························································································· 120 
Publications ························································································· 126 
Thesis Examiner Committee ···································································· 127 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 III 
Chart Information 
Figures   
Chapter I: 
Fig. I-2.1 Crystal structure of the complex of receptor and ligand, receptor part and 
ligand part ···························································································· 10 
Fig. I-2.2 The p66 domain was modified by generating the missing residues by 
homology modeling ················································································· 12 
Fig. I-2.3 Water molecule wrapping of model structure of MMP-1 ······················ 12 
Fig. I-2.4: The diagram of deformation effect for bond, angle, and dihedral angle 
·········································································································· 13 
Fig. I-2.5 RMSD calculation between MMP-1 crystal structure and pattern 
#100····································································································· 14 
Fig. I-3.1 Crystal structure and Orientation score of MMP-1 ····························· 18 
Fig. I-3.2 Six conformations of MMP-1 patterns with the top Orientation score in 
comparison with the crystal structure ·························································· 19 
Fig. I-3.3 Six conformations of MMP-1 patterns with the top Z-score, in comparison 
with the crystal structure ········································································· 20 
Fig. I-3.4 Crystal structure and Orientation score of HIV-1 integrase ·················· 24 
Fig. I-3.5 Six conformations of HIV-1 integrase patterns with the top Orientation score, 
in comparison with the crystal structure ······················································ 25 
Fig. I-3.6 Six conformations of HIV-1 integrase patterns with top Z-scores are 
compared with crystal structures ······························································· 26 
Fig. I-3.7 The residues with strong binding affinity of 6 patterns for HIV-1 integrase 
·········································································································· 27 
Fig. I-3.8 Crystal structure and Orientation score of HLA ································ 32 
Fig. I-3.9 Six conformations of HLA patterns with the top Orientation score, in 
comparison with the crystal structure ·························································· 33 
Fig. I-3.10 Six conformations of HLA patterns with top Z-scores are compared with 
crystal structures ··················································································· 34 
Fig. I-3.11 The residues with large binding energies of patterns #1 and #39 for HLA 
··········································································································· 35 
Fig. I-3.12 The detail of the binding conformation of patterns #1 and #39 for HLA · 38 
Fig. I-3.13 Crystal structure and Orientation score of HIV-1 protease homodimer ·· 42 
Fig. 3.14 Six conformations of HIV-1 protease patterns with the top Orientation score, 
 IV 
in comparison with the crystal structure ······················································ 43 
Fig. I-3.15 Six conformations of HIV-1 protease patterns with the top Z-score, in 
comparison with the crystal structure ·························································· 44 
Fig. I-3.16 The residues with large binding energies of patterns #1 and #38 for HIV-1 
protease ······························································································· 45 
Fig. I-3.18 Crystal structure and Orientation score of HIV-1 reverse transcriptase 
heterodimer ·························································································· 51 
Fig. I-3.19 Six conformations of HIV-1 reverse transcriptase heterodimer with the top 
Z-score, in comparison with the crystal structure ··········································· 53 
Fig. I-3.20 Crystal structure and Orientation score of Fab complex ····················· 56 
Fig. I-3.21 Six conformations of Fab complex with the top Orientation score, in 
comparison with the crystal structure ·························································· 57 
Fig. I-3.22 Six conformations of Fab complex with the top Z-score, in comparison with 
the crystal structure ················································································ 58 
Fig. I-3.23 The classification of secondary structure for HLA protein complex ······· 63 
Fig. I-4.1 MMP-1 complexe with water molecules ··········································· 72 
Fig. I-4.2 Potential curve relative to the distance of two atoms in interaction ········· 74 
Fig. I-4.3 Comparing the conformation of HIV-1 reverse transcriptase pattern #93 
before and after optimizations ··································································· 76 
Fig. I-4.4 Conformations of pattern #93 of HIV-1 reverse transcriptase, in comparison 
with the crystal structure ········································································· 79 
Fig. I-4.5 The residues with large binding energies of crystal structure and pattern #93 
for HIV-1 reverse transcriptase ································································· 80 
Fig. I-4.6 Crystal structure of Fab domain ···················································· 83 
Fig. I-4.7 Comparing the residues with large binding energies in HA protein and Fab 
domain ································································································ 86 
 
Chapter II: 
Fig. II-3.1: Structures of Aβ42 peptides at the final point of the 1 μs MD simulation 
··········································································································· 98 
Fig. II-3.2: Structures of six Aβ42 peptides after the 5 μs simulations ················· 102 
Fig. II-3.3.: Conformational changes of six Aβ1-42 peptides during the 5 μs simulation 
in the mixed solution of dioxane and water ·················································· 103 
Fig. II-3.4: Conformational changes of six Aβ1-42 peptides during the 5 μs MD 
simulation in the mixed solution of dioxane and water ···································· 104 
Fig. II-3.5: Conformational changes of six Aβ1-42 peptides during the 5 μs simulation 
 V 
in the water ························································································· 105 
Fig. II-3.6: Conformational changes of six Aβ1-42 peptides during the 5 μs MD 
simulation in the water ··········································································· 106 
Fig. II-3.7: Time course of changes in surface area, hydrogen bond, and hydrogen 
bond interaction ··················································································· 108 
Fig. II-3.8: Changes in the number of inter-molecular hydrogen bonds that every Aβ 
peptide formed in the 5 μs simulation ························································· 110 
Fig. II-4.1: Frequencies of the secondary structures appearing in the 5 μs simulation 
for the Aβ42 peptides in the mixed solution ················································· 112 
Fig. II-4.2: Frequencies of the secondary structures appearing in the 5 μs simulation 
for the Aβ42 peptides in the aqueous solution ··············································· 113 
Fig. II-4.3: Cluster analysis on the 60 snapshot structures of six Aβ42 peptides 
acquired every 0.1 μs for the last 1 μs ························································· 115 
 
Tables  
Chapter I: 
Table I-2.1 Residue number of receptor and ligand of the proteins in calculation ···· 15 
Table I-3.1 Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for MMP-1 ·················································································· 21 
Table I-3-2 Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for HIV-1 integrase ······································································· 29 
Table I-3.3 Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for HLA ····················································································· 39 
Table I-3.4 Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for HIV-1 protease ········································································ 48 
Table I-3.5 Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for HIV-1 reverse transcriptase heterodimer ······································· 54 
Table I-3.6 Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for Fab domain ············································································ 59 
Table I-3.7 Ranking of conformations, based on modified Orientation score with per 
factor values ························································································· 64 
Table I-4.1 The labeled residues with large binding energy in the crystal structure and 
pattern #93 ··························································································· 81 
Table I-4.2 Ranking of conformations, based on Orientation score of CDRs for Fab 
domain ································································································ 84 
 VI 
 
 
 
 
 
 
 
 
 1 
 
 
 
 
 
 
Chapter I 
 
Computational Prediction of Protein Complex Structure 
  
 2 
I-Abstract 
The protein-protein interactions (PPI) are important in the research field of drug 
design based on structural biology because they are fundamental information to 
understand the mechanism of signal transfer or the enzymatic action of proteins. For 
the protein complex structures that are difficult to be crystallized, a large amount on 
single proteins is expected to be utilized to predict the structures of the protein-protein 
complexes by in silico approaches.  
The crystal structures of matrix metalloproteinase-1 (MMP-1) and collagen complex, 
HIV integrase and DNA complex, human leukocyte antigen (HLA) heavy and light 
chains, HIV protease homodimer, HIV reverse transcriptase p66 and p51 heterdimaer, 
Influenza virus hemagglutinin (HA) and its antibody with fragment of antigen-binding 
(Fab) were selected in this study. Complexes were divided into receptors and ligands. 
The divided two parts were re-combined by the approach in this study. The potency for 
predicting the protein-protein complex was evaluated by the accuracy of the 
re-combined model structure relative to the crystal structure. 2,000 binding patterns 
were generated by ZDock server with Z-score value. Based on Z-score, the top 960 
conformations were selected from the 2,000 patterns. The 960 patterns were ranked 
again with the Orientation score. Out of the 6 selected complexes, 4 predictions for 
complexes gave the reliable answers. The pattern with the closest to the crystal 
structure was found within the top 5 in the order of the Orientation score for these 4 
complexes. 
   According to the secondary structure of residues, Orientation scores were divided 
into helix-score (α-helix), sheet-score (β-sheet), and loop-score (the others). When 
loop-scores were multiplied by 0.7, the ranking was improved. 
 3 
I-1. Introduction 
  Protein-protein interaction (PPI) has attracted much attention in structure biology, 
because PPI is a key factor to understand the mechanism of signal transfer in cell or to 
determine the binding site suitable for drug target.1, 2 With the progress in technology of 
X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, the 
difficulty of obtaining three-dimensional structure of protein is reduced.3 However, the 
number of entries on the structures of the protein-protein complexes is quite little in 
Protein Data Bank (PDB), and the information of the protein-protein complex is highly 
demanded. In contrast to PPI, there is abundant data on single proteins in PDB.4 Single 
protein can be a component of protein complex. Therefore the computational prediction 
of the protein-protein complex from the component proteins will be useful for promoting 
protein engineering and drug discovery. The accurate prediction is necessary to solve 
the problem of obtaining the protein complex structures that are difficult to be 
crystallized.  
Generally, there are two steps in the prediction of the protein-protein complex: 
docking and scoring. “Docking” means that two components of proteins are assembled 
into one complex. Sufficient number of complex structures is required to generate an 
adequate complex conformation. “Scoring” is the process of selecting the adequate 
complex conformation from many generated structures.5 On the basis of a scoring 
function, the scores of complex conformations are calculated and ranked, and then, the 
most probable confirmation is determined. Hence, the scoring function is crucial in the 
process of prediction. Currently, the scoring function is divided into two approaches: 
force field based scoring and experience based scoring.6, 7 The experience based and 
force field based scores are sometimes combined, but the experience based scores are 
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more dominant. Some recent programs for PPI prediction sometimes contain both with 
force field based scoring and experience based scoring. For example, ZDock score 
estimates the binding affinity from a sum of pairwise shape complementarity, 
electrostatic potential, and interface atomic contact energies.8-10 The score of F2 Dock is 
calculated by shape complement, electrostatic potential, interface propensity, and van 
der Waals energy.5 In the calculation of force field based scores, many programs focused 
on electrostatic and VDW potential energies. The molecular mechanics Poisson 
Boltzmann Surface Area (MM/PBSA) calculation of AMBER gives the difference 
between a complex and their components and suggests the probable complex 
conformation.11, 12 PPIs are dominated by hydrophobic and hydrogen bonding 
interactions. Therefore, developing an approach that calculates hydrophobic and 
hydrogen bonding energy is worthy. 
Another problem in PPI structural prediction is the optimization of the complex 
structure after docking. There are two reasons why structural optimization is necessary. 
Firstly, rigid-body protein-protein docking sometimes makes contact atoms too close, 
which causes the interdigitation of protein and unfavorable repulsion, the propulsion is 
especially problematic in force field based score. Flexibility-implemented 
protein-protein docking can improve the problem, but it may not be useful when the 
atoms of the main chain are interdigitated. The second reason is the allosteric effect. 13 
When a protein makes a contact to another one, the structural transformation 
sometimes brings a considerable gain in binding energy, and hence, structural change is 
inevitable. Therefore, the rigid-body protein-protein dock is difficult to find the 
adequate complex conformation poses, unless single component proteins are 
considerably inflexible. For the practical application of PPI prediction, this problem 
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must be overcome.  
In this study, we developed a prediction approach for PPI. Firstly, sufficient complex 
conformations were generated by ZDock. Then the program named Orientation 
optimizes the complex structures generated from the conformation of rigid-body docking 
by ZDock. Finally, the binding affinity of every confirmation was calculated to select the 
adequate structure. The step is called “re-scoring”. Re-dock method was adopted 
evaluate to prove the accuracy of an approach. The complex was separated into two 
single parts first. The docking poses of two parts were generated by ZDock and the 
binding structures were calculated by Orientation. The generated complex structures 
were ranked again by the re-scores and the complex conformation that gives the top 
score was identified as the most probable structure.   
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I-2. Method 
I-2.1 Selecting protein 
To evaluate the accuracy of the approach proposed in this study, the examinatim 
with diverse protein complexes is necessary. The data files on six protein complex 
structures were downloaded from RCSB Protein Data Bank (PDB, hppt://www.rcsb.org）. 
Matrix metalloproteinase-1(MMP-1) and collagen complex (PDB code: 4AUO), HIV-1 
integrase and DNA complex (PDB code: 3L2Q), Human Leukocyte Antigen (HLA) major 
istocompatibility complex (MHC) class I and β2-microglobulin (PDB code: 2BCK), HIV-1 
protease homodimer (PDB code: 1RPI), HIV-1 reverse transcriptase p51 and p66 
domain heterodimer (PDB code:3DLK), Influenza virus hemagglutinin (HA) and 
corresponding Fragment of antigen binding(Fab) complex(PDB code: 2VIR) were 
selected to the examinating (Fig. I-2.1 left).14-19 In this study, not only protein-protein 
complex, but also protein-DNA complex (HIV integrase) were included. For the variety 
of samples, protein-protein and protein-DNA complexes were selected. Furthermore, as 
the examples of protein-protein complexes, heterodimer, homodimer, and antibody were 
included. 
I-2.2 Docking 
All the complexes were divided into two parts, for example, enzyme and substrate, 
receptor and ligand, heavy and light chains, etc. Hereafter, one of the divided parts with 
more residues is called receptor, and the part with fewer residues or others is ligand in 
this study (Fig. I-2.1 middle and right). The sequences of missing residues of 
downloaded protein files were identified in National Center for Biotechnology 
Information (NCBI). 20 The coordinates of the missing residues and atoms were 
generated by MODELLER Ver. 9.12 (Fig. I-2.2).21, 22 Afterward, receptors and ligands 
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were inputed to ZDock server (http://zdock.umassmed.edu/) and 2000 patterns were 
generated. ZDock provides Z-score that was calculated by pairwise shape 
complementarity and electrostatic potential. Based on Z-score generated by ZDock, 
patterns were ranked and top 960 patterns were selected for the next-step calculation. 
I-2.3 Score 
960 conformations were wrapped by water molecule layers (Fig. I-2.3). The 
thickness of water layers is about 2Å. Afterward, hydrogen atoms on the respective 
residues were generated by a utility program, tleap of AMBER16, and then, the 
coordinate and topology files were generated for calculation (Table I-2.1).23, 24 The 
optimization and scoring were performed by Orientation.25 Optimization makes the 
docked structures of patterns stable (see discussion 4.4). Score is used to evaluate the 
binding affinity between receptors and ligands. 
The calculation of Orientation force field contains intra-molecular and 
inter-molecular terms.  
Intra-molecular interaction: 
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Above function, deformation effect is described in the first three terms (Fig I-2.4). 
req and θeq are equilibrium structural parameters; Kr, Kθ, Vn are force constants; n is 
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multiplicity and γ is phase angle for torsional angle parameters. Those terms represent 
the energies generated from the change of bond distance from the equilibrated value, 
angles and dihedral angles. The terms of electrostatic and van der Waals potential 
energies are given in the last two terms. In this part, ligands and receptors are 
calculated respectively. 
Inter-molecular interaction: 
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In the part of inter-molecular interaction, “phobic” and “philic” terms is used to 
calculate hydrophobic and hydrophilic contacts. The terms of π-π and π-XH(X=C, N, O, 
S) areadded to the score energy, if the calculated atoms belong to aromatic rings. In 
these three terms, One of the two atoms in calculated pair belongs to ligand and the 
other belongs to receptor respectively. In contrast, the term of “repulsive” is calculated 
the contacts between two atoms without any constraint on (ligand or receptor). The 
third term of “specific” is used to calculate the contacts between arbitrary two atoms  
I-2.4 Statistics  
For verifying the accuracy of the Orientation score, the patterns were ranked by 
Orientation scores and six patterns with the top scores were selected. Afterwards, the 
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root mean squared deviation (RMSD) between every selected pattern and the crystal 
structure was calculated by PyMOL.26 Scheme is shown in Fig. I-2.5. The receptor part 
of the pattern (yellow) was aligned the receptor part of crystal structure (cyan). The 
RMSD of ligand of pattern (green) from the crystal structure (pink) was calculated. The 
operation is applied only the atoms of main chain (Cα, C, N). The RMSD is obtained by, 
      
 
 
                             
 
   
 
(xi,yi,zi) is coordinate of pattern, and (Xi, Yi, Zi) is coordinate of crystal structures. “n” 
is the number of calculated atoms.  
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(a) 
 
(b) 
 
(c) 
 
(d) 
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(e) 
 
(f) 
 
Fig. I-2.1: Crystal structure of the complex of receptor (green) and ligand (pink) (left), 
receptor part (middle) and ligand part (right). (a) MMP-1. (b) HIV-1 integrase. (c) HLA. 
(d) HIV-1 protease. (e) HIV-1 reverse transcriptase. (f) Fab. 
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(a)                                  (b) 
        
Fig. I-2.2: HIV-1 reverse transcriptase. The p66 domain was modified by generating the 
missing residues by homology modeling. (a) Before modification. (b) After modification.  
 
(a)                                   (b) 
 
Fig. I-2.3: Water molecule wrapping of model structure of MMP-1. (a) The initial model. 
(b) The wrapped model.  
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(a)  
 
(b) 
 
(c) 
 
Fig. I-2.4: The diagram of deformation effect for bond (a), angle (b), and dihedral angle 
(d). req and θeq are equilibrium structural parameters. r and θ the calculated value of 
bond length and bond angle. Φ is torsional angle. 
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Fig. I-2.5: RMSD calculation between MMP-1 crystal structure and pattern #100. The 
yellow part is the receptor of pattern #100. The green part is ligand of pattern #100. The 
cyan part is the receptor of crystal structure. Pink part is ligand of the crystal structure. 
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Table I-2.1: Residue number of receptor and ligand of the proteins in calculation.  
Protein PDB 
code 
Sequence of 
receptor 
(initial) 
Sequence of 
ligand (initial) 
Sequence of 
receptor (after 
tleap) 
Sequence of 
ligand (after 
tleap) 
MMP-1 4AUO A.81-447 C.963-1001 
D.963-998 
E.963-995 
1-367 368-475 
HIV-1 
integrase 
3L2Q A.10-374 C.1-19 
D.1-17 
1-365 366-403 
HLA 2BCK A.1-2886 B.0-99 1-286 287-386 
HIV-1 
protease 
1RPI A.1-99 B.1-99 1-99 100-198 
HIV-1 RT 3DLK A.3-554 B.6-428 1-552 553-975 
Fab 2VIR A.1-210 
B.1-221 
C.43-308 1-431 432-698 
When hydrogen atoms were added to protein complexes by tleap of AMBER16, the 
sequence number was changed and started from number 1. The chain names were 
deleted. The receptor or ligand was not necessarily required to be a single chain.   
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I-3. Results 
I-3.1 Orientation score  
960 patterns were selected to calculate the Orientation score for every kind of 
protein complexes. To compare Orientation score, ZDock score was also listed. The top 6 
patterns based on the ranking by Orientation score and ZDock score were observed, 
respectively. 
I-3.1.1 MMP-1 
The crystal structure is shown in Fig. I-3.1. Collagen homotrimer makes contact to 
MMP-1 with two sites.14 At one site, collagens are bound to the catalytic domain, and at 
the other site, collagens are bound to hemopexin-like C-terminal domain. At the 
catalytic domain, there exists a large groove to hold collagens. Hemopexin-like 
C-terminal domain is a symmetrical homotetramer, and there is no groove. 
The pattern number was decided by Z-score. Hence, pattern #1 is the complex with 
the best Z-score, and pattern #2 follows pattern #1 with the second best Z-score.                                                                                                                                                                                                                            
Fig. I-3.1(b) illustrated Orientation score and Z-score for 960 conformations. The 
patterns #89, #4, #70, #758, #7 and #78 were selected as the top six patterns in the 
order of Orientation score, and the patterns #1-#6 were selected to represent the result 
of Z-score. The structures of 6 patterns based on the ranking of Orientation score and 6 
patterns from Z-score were shown in Fig. I-3.2 and Fig. I-3.3, respectively. The RMSD 
value between the crystal structure and the top 20 patterns selected based Orientation 
and Z-scores are shown in Table I-3.1. 
In the Orientation score, the RMSD of pattern #89 with Orientation score ranking 
No. 1 is 61.3Å, but the structure resembles to crystal structure (Fig. I-3.2(a)). The 
reason for the high RMSD is that collagens (ligand) are located on the same position of 
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the ligand of the crystal structure in conformation #89 but with a different orientation. 
The same case also happened on pattern #78. 
The pattern #70 with the lowest RMSD is ranking 3 in the order of Orientation score, 
and the pattern #4 with the third lowest RMSD is ranking 2. All of the conformations of 
top 6 patterns selected by Orientation score are similar to crystal structure. Accordingly 
the result of MMP-1 indicates the potency of prediction. 
In Z-scores within the top 6 patterns, the RMSDs of only patterns #1 and #4 are less 
than 10Å, and the pattern with the lowest RMSD is ranking 70 in the order of Z-score. 
Hence, the result of Z-score in MMP-1 complex prediction is worse than that of 
Orientation score. 
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 (a) 
 
                            catalytic domain 
 
                                 hemopexin-like C-terminal domain  
 
 
(b) 
 
Fig. I-3.1: (a) Crystal structure of MMP-1. MMP-1 is green and collagen is pink. In the 
MMP-1, upper part is catalytic domain, and down part is hemopexin-like C-terminal 
domain. (b) x-axis means 960 conformations, and y-axes indicates the values of scores. 
The scale on the right side is about Orientation score and the values are represented by 
green line. The scale on the left side is about Z-score and the values are represented by 
pink line. Six patterns with top Orientation scores are labeled with pattern number. 
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(a)                                  (b) 
 
(c)                                  (d) 
 
(e)                                  (f) 
 
Fig. I-3.2: Six conformations of MMP-1 patterns with the top Orientation score, in 
comparison with the crystal structure. Conformations of patterns are marked in pink 
and the crystal structure is in green. (a) Pattern #89. (b) Pattern #4. (c) Pattern #70. (d) 
Pattern #100. (e) Pattern #7. (f) Pattern #23. 
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(a)                               (b) 
 
 
 
 
 
 
(a)                               (d) 
 
 
 
  
 
(e)                                (f) 
 
 
 
 
 
 
Fig. I-3.3: Six conformations of MMP-1 patterns with the top Z-score, in comparison 
with the crystal structure. Conformations of patterns are marked in pink and the 
crystal structure is in green. (a) Pattern #1. (b) Pattern #2. (c) Pattern #3. (d) Pattern #4. 
(e) Pattern #5. (f) Pattern #6. 
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Table I-3.1: Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for MMP-1. 
 
Orientation RMSD(Å) ZDock RMSD(Å) rmsd1) RMSD(Å) 
1 89 61.28  1 6.55  70 3.52  
2 4 5.33  2 23.37  497 5.30  
3 702) 3.52  3 13.98  4 5.33  
4 758 8.80  4 5.33  32 5.47  
5 7 6.27  5 40.77  26 5.99  
6 78 61.57  6 10.13  23 6.09  
7 23 6.09  7 6.27  208 6.15  
8 121 63.66  8 61.65  7 6.27  
9 100 34.16  9 6.94  1 6.55  
10 497 5.30  10 61.00  30 6.60  
11 426 29.09  11 10.57  416 6.92  
12 29 33.82  12 14.52  9 6.94  
13 111 58.23  13 35.36  67 7.00  
14 9 6.94  14 32.45  210 7.96  
15 843 57.83  15 50.33  846 8.62  
16 504 9.01  16 67.44  758 8.80  
17 20 33.07  17 65.29  257 8.85  
18 353 25.59  18 35.18  567 8.93  
19 64 63.03  19 54.10  116 8.97  
20 476 31.24  20 33.07  504 9.01  
1) rmsd means the order based on RMSD. 
2) The pattern with the lowest RMSD is indicated by red. 
 
 
 
 
 
 22 
I-3.1.2 HIV-1 integrase 
The crystal structure of HIV-1 integrase and DNA complex is shown in Fig. I-3.4(a). 
15 DNA in the ligand is double-helix form, but DNA is split into two single-stranded 
forms at the lower terminal region and is bound to HIV-1 integrase. There are several 
obvious grooves in HIV-1 integrase, and it is hard to predict which one is the correct site 
to bond to DNA. 
Fig. I-3.4(b) illustrates Orientation score and Z-score for 960 patterns. Patterns 
#278, #171, #874, #54, #822 and #299 were selected as the top six patterns based on 
Orientation score. The structures of 6 patterns in the order of Orientation score and 6 
patterns from Z-score are shown in Fig. I-3.5 and Fig. I-3.6, respectively. The RMSD 
value between the crystal structure and top 20 patterns selected on the basis of 
Orientation and Z-scores is shown in Table I-3.2. 
The conformation of pattern #171 with Orientation score ranking No. 2 is the closest 
to the crystal structure among 960 patterns. Pattern #874 and pattern #299, 
conformations of which are similar to the crystal structure, are ranking the 3rd and 4th 
in the order of Orientation score, respectively, but the directions of DNAs are opposite to 
that is from the crystal structure. Since there is little difference in the main chains of 
DNAs, it is difficult to predict the binding pose including DNA direction.  
For the six patterns mentioned above, the energy of every residue was examined. 
The residues with a large binding energy (the sum of hydrophobic effect and hydrophilic 
effect in Orientation score is lower than -5.0) were labeled in Fig. I-3.7 c-h with pink. 
Tyr203, Gln206, Lys213 and Arg220, mainly contribute to the binding to DNA. Five 
residues concentrated on helix and loop are labeled with pink color in Fig. I-3.7b. 
Though DNAs have different orientations, the centre of binding site of HIV-1 integrase 
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has been accurately predicted.  
According to the result of Z-score, all the RMSDs of top 6 patterns exceed over 10Å 
and the pattern with the lowest RMSD ranks the 70th in the order by Z-score. Hence, 
the result of Z-score is less accurate than that of Orientation score in the prediction of 
HIV-1 integrase complex. 
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(a) 
 
(b) 
 
Fig. I-3.4: (a) Crystal structure of HIV-1 integrase complex. HIV-1 integrase is green 
and DNA is pink. The circles labeled the grooves in HIV-1 integrase as examples. (b) 
x-axis means 960 conformations, and y-axes indicates the values of scores. The scale on 
the right side is about Orientation score and the values are represented by green line. 
The scale on the left side is about Z-score and the values are represented by pink line. 
Six patterns with top Orientation scores are labeled with pattern number.  
 25 
(a)                                 (b) 
 
(c)                                 (d) 
 
(e)                                 (f)  
 
Fig. I-3.5: Six conformations of HIV-1 integrase patterns with the top Orientation score, 
in comparison with the crystal structure. Conformations of patterns are marked in pink 
and the crystal structure is in green. (a) Pattern #278. (b) Pattern #171. (c) Pattern #874. 
(d) Pattern #54. (e) Pattern #822. (f) Pattern #299. 
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(a)                                 (b) 
 
(c)                                 (d) 
 
(e)                                 (f)  
 
Fig. I-3.6: Six conformations of HIV-1 integrase patterns with top Z-scores are compared 
with crystal structures. Conformations of patterns are marked in pink and the crystal 
structure is in green. (a) Pattern #1. (b) Pattern #2. (c) Pattern #3. (d) Pattern #4. (e) 
Pattern #5. (f) Pattern #6. 
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(a)                                    (b) 
 
(c)                                    (d) 
 
(e)                                    (f)  
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(g)                                    (h) 
 
Fig. I-3.7: The residues with strong binding affinity of 6 patterns for HIV-1 integrase. (a) 
The crystal structure. (b) It is the enlarged figure of the part in the rectangle of (a) when 
DNA is removed from the crystal structure. The pink indicates where the residues with 
strong avidity are concentrated. (c) The residues of pattern #278 are labeled with pink 
color. The residues are Ser96, Ser100, Tyr132, Lys150, Ser155, Lys159, Asp176, Tyr203, 
Glu212, Arg317, Arg320 and Arg327. (d) The labeled residues of pattern #171 comprise 
Gln206, Gly209, Lys210, Arg213, Ser216, Arg220, Lys336, Leu338 and Asn339. (e) The 
labeled residues of pattern #874 comprise Arg105, Tyr203, Gln206, Lys210, Arg213, 
Asn215, Ser216 and Arg220. (f) The labeled residues of pattern #54 comprise Arg105, 
Arg108, Lys115, Lys210, Arg213, Asp217, Arg220, Tyr248, Lys263, Phe269, Gln272, 
Tyr294, Ser297 and Thr342. (g) The labeled residues of pattern #822 comprise Arg105, 
Arg108, Lys210, Arg213, Lys214, Asp217, Arg220, Lys224 and Phe269. (h) The labeled 
residues of pattern #299 comprise Ser100, Arg105, Tyr203, Gln206, Gln212, Arg213, 
Lys219 and Tyr248. 
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Table I-3-2: Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for HIV-1 integrase. 
 
Orientation RMSD(Å) ZDock RMSD(Å) rmsd1) RMSD(Å) 
1 278 45.26  1 48.93  171 2.11  
2 1712) 2.11  2 27.88  874 18.56  
3 874 18.56  3 28.58  555 20.52  
4 54 27.59  4 29.96  776 22.59  
5 822 28.41  5 35.58  806 23.20  
6 299 48.42  6 38.17  444 23.25  
7 634 49.02  7 40.81  10 23.59  
8 193 44.95  8 29.54  813 23.67  
9 882 24.67  9 28.26  216 23.87  
10 843 26.04  10 23.59  383 24.08  
11 605 48.75  11 54.01  375 24.42  
12 672 35.64  12 30.28  366 24.48  
13 322 27.93  13 36.74  882 24.67  
14 768 37.78  14 56.92  223 24.69  
15 458 47.03  15 44.30  352 24.79  
16 637 28.10  16 37.59  804 24.80  
17 730 26.87  17 38.38  802 24.95  
18 555 20.52  18 29.96  128 25.09  
19 326 27.33  19 30.64  614 25.17  
20 828 61.45  20 40.60  823 25.18  
1) rmsd means the order based on RMSD. 
2) The pattern with the lowest RMSD is indicated by red. 
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I-3.1.3 HLA 
HLA protein complex is composed of MHC class I and β2 microglobulin, and its 
crystal structure is shown in Fig. I-3.8(a).16 MHC class I is a L-shaped protein. The 
upper part is constituted by two α-helices and β-sheets. The two helices form a groove 
and hold a peptide. At the down part, β-sheets and loops are related to the binding to β2 
microglobulin. β2 microglobulin is composed of β-sheet and loops and bound to MHC 
class I tightly. The interface between ligand and receptor is large.  
Fig. I-3.8(b) illustrates the Orientation score and Z-score for 960 patterns. Pattern 
#39, #605, #446, #640, #1, and #416 were selected as the top six patterns based on 
Orientation score. The structures of top 6 patterns in the order of Orientation score and 
6 patterns from Z-score are shown in Fig. I-3.9 and Fig. I-3.10, respectively. The RMSD 
value between the crystal structure and the top 20 patterns selected based on 
Orientation and Z-scores are shown in Table I-3.3. 
The conformation of pattern #1 with Orientation score ranking No. 5 is the closest to 
the crystal structure among 960 patterns. The conformation of pattern #39 with the best 
Orientation score is also similar to the crystal structure. The difference between pattern 
#39 and #1 was compared in terms of energy, and the residues with large binding 
energies were examined.  
There are 13 residues with strong binding affinity on the receptor in pattern #1, and 
there are 19 residues with strong binding affinity on the receptor in pattern #39 (Fig. 
I-3.11(a, b)). 8 residues among them are common, Phe8, Typ27, Gln32, Lys121, Arg202, 
Glu232, Arg234, and Gln242. This means that there are similar binding sites for the 
receptor between patterns #1 and #39. The same analysis was performed for the ligand, 
too. There are 17 residues with strong binding affinity on the ligand in pattern #1, and 
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21 residues for the ligand in pattern #39 (Fig. I-3.11(c, d)). 15 residues among them are 
common. This also suggested that there are similar binding sites for the ligand between 
patterns #1 and #39.  
Fig. I-3.12 shows the reason why the conformation of pattern #1 is different slightly 
to pattern #39. Glu232, Arg234, Gln295, and Asn311 are common in both pattern #1 and 
pattern #39. However, in pattern #1, Asn311 bonds to Pro235 and Gln295 bond to 
Glu232. In pattern #39, Asn311 bond to Arg234, and Gln295 bond to Glu232 and 
Leu230. The binding residue with large binding energy is the same, but the binding site 
is staggered. 
According to the result of Z-score, all the RMSDs of top 6 patterns are less than 10Å, 
and the pattern with the lowest RMSD ranks the 1st in the order by Z-score. The reason 
is that there is a large area at the interface of the complex. 
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(a) 
 
(b) 
 
Fig. I-3.8: (a) Crystal structure of HLA complex. MHC class 1 is green and β2 
microglobulin is pink. (b) x-axis means 960 conformations, and y-axes indicates the 
values of scores. The scale on the right side is about Orientation score and the values 
are represented by green line. The scale on the left side is about Z-score and the values 
are represented by pink line. Six patterns with top Orientation scores are labeled with 
pattern number. 
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(a)                                    (b) 
               
(c)                                    (d) 
               
(e)                                    (f) 
              
Fig. I-3.9: Six conformations of HLA patterns with the top Orientation score, in 
comparison with the crystal structure. Conformations of patterns are marked in pink 
and the crystal structure is in green. (a) Pattern #39. (b) Pattern #605. (c) Pattern #446. 
(d) Pattern #640. (e) Pattern #1. (f) Pattern #416. 
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(a)                                    (b) 
              
(c)                                    (d) 
                   
(e)                                    (f) 
              
Fig. I-3.10: Six conformations of HLA patterns with top Z-scores are compared with 
crystal structures. Conformations of patterns are marked in pink and the crystal 
structure is in green. (a) Pattern #1. (b) Pattern #2. (c) Pattern #3. (d) Pattern #4. (e) 
Pattern #5. (f) Pattern #6. 
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(a)  
 
(b) 
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(c)   
 
(d) 
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Fig. I-3.11: The residues with large binding energies of patterns #1 and #39 for HLA. 
MHC class 1 is green and β2 microglobulin is pink. The residues with large binding 
energies are labeled with blue. (a) Receptor of pattern #1. Phe8, Ile23, Tyr27, Gln32, 
Arg35, Gln96, Lys121, Hie192, Arg202, Glu232, Arg234, Pro235, Gln242 were labeled. 
(b) Receptor of pattern #39. Phe8, Tyr27, Asp30, Gln32, Thr94, Gln96, Tyr113, Asp119, 
Gly120, Lys121, Asp122, Arg202, Glu229, Leu230, Val231, Glu232, Arg234, Gln242, 
Trp244 were labeled. (c) Ligand of pattern #1. Ile288, Lys293, Gln295, Tyr297, Ser298, 
Arg299, Asn311, Tyr313, Ser315, Asp340, Leu341, Phe343, Lys345, Trp347, Tyr350, 
Asp385, Met386 were labeled. (d) Ligand of pattern #39. Met287, Ile288, Gln289, 
Gln295, Tyr297, Ser298, Arg299, Asn311, Tyr313, Ser315, Hie318, Ser320, Asp321, 
Asp340, Leu341, Phe343, Lys345, Trp347, Arg384, Asp385, Met386 were labeled. 
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(a) 
 
(b) 
 
Fig. I-3.12: The detail of the binding conformation of patterns #1 and #39 for HLA. MHC 
class 1 is green and β2 microglobulin is pink. The residues with large binding energies 
in the MHC class 1 andβ2 microglobulin were labeled with blue and yellow, respectively. 
(a) Pattern #1. (b) Pattern #39. 
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Table I-3.3: Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for HLA. 
 
Orientation RMSD(Å) ZDock RMSD(Å) rmsd1) RMSD(Å) 
1 39 6.90  12) 2.20  1 2.20  
2 605 12.85  2 3.07  4 2.89  
3 446 22.26  3 7.07  2 3.07  
4 640 37.57  4 2.89  583 5.33  
5 12) 2.20  5 5.38  5 5.38  
6 416 25.33  6 6.53  9 5.52  
7 117 9.58  7 7.92  46 6.34  
8 434 8.83  8 11.90  6 6.53  
9 8 11.90  9 5.52  209 6.69  
10 67 12.60  10 35.87  39 6.90  
11 946 36.78  11 63.81  3 7.07  
12 521 26.12  12 30.57  99 7.37  
13 583 5.33  13 33.47  45 7.45  
14 370 41.62  14 57.51  7 7.92  
15 2 3.07  15 27.60  227 8.48  
16 14 57.51  16 27.84  19 8.78  
17 50 38.58  17 10.32  434 8.83  
18 331 23.51  18 28.21  257 8.83  
19 677 23.97  19 8.78  265 8.88  
20 84 10.34  20 20.48  24 9.40  
1) rmsd means the order based on RMSD. 
2) The pattern with the lowest RMSD is indicated by red. 
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I-3.1.4 HIV-1 protease 
The crystal structure of HIV-1 protease is shown in Fig. I-3.13(a).17 Because HIV-1 
protease is homodimer, the structure for receptor and ligand are the same as each other. 
The secondary structure of the major binding sits are loops, and loops interlace to each 
other between receptor and ligand. It makes the interface area large.  
Fig. I-3.13(b) illustrates the Orientation score and Z-score for 960 patterns. Patterns 
#38, #1, #13, #4, #11 and #12 were selected as the top six patterns based on Orientation 
score. The structures of 6 patterns in the order of Orientation score and 6 patterns from 
Z-score are shown in Fig. I-3.14 and Fig. I-3.15, respectively. The RMSD value between 
the crystal structure and the top 20 patterns selected based on Orientation and Z-scores 
are shown in Table I-3.4. 
The conformation of pattern #1 with Orientation score ranking No. 2 is the closest to 
the crystal structure among 960 patterns. The conformations of patterns #4, #11 and 
#12 with the 4th, 5th and 6th ranking in the order of Orientation score are also similar 
to the crystal structure.  
Pattern #38 has the best Orientation score. The comparison between pattern #38 
and #1 was performed, and the residues with large binding energies were examined. 
There are 32 residues with large binding energies in pattern #38, and 30 residues with 
large binding energies in pattern #1 (Fig. I-3.16(a, b)). 19 residues among them are 
common (Fig. I-3.16(c, d)). Hence, #38 and #1 are quite similar to each other. However, 
in pattern #1 there are additional weak contacts at the bottom of the complex, such as 
Pro81 and Ile149 (Fig. I-3.16(e)). It makes pattern #1 structural stability. 
According to the result of Z-score, the RMSDs of the top 5 patterns are less than 10Å. 
The pattern with the lowest RMSD ranks the 1st in the order by Z-score, the pattern 
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with the second-lowest RMSD ranks the 3rd in the order by Z-score. The reason is that 
the interlaced structure makes an interface area large in the complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 42 
(a) 
 
(b) 
 
Fig. I-3.13: (a) Crystal structure of HIV-1 protease homodimer. Receptor is green and 
ligand is pink. (b) x-axis means 960 conformations, and y-axes indicates the values of 
scores. The scale on the right side is about Orientation score and the values are 
represented by green line. The scale on the left side is about Z-score and the values are 
represented by pink line. Six patterns with top Orientation scores are labeled with 
pattern number. 
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(a)                                   (b) 
 
(c)                                   (d) 
 
(e)                                   (f)  
 
Fig. I-3.14: Six conformations of HIV-1 protease patterns with the top Orientation score, 
in comparison with the crystal structure. Conformations of patterns are marked in pink 
and the crystal structure is in green. (a) Pattern #38. (b) Pattern #1. (c) Pattern #13. (d) 
Pattern #4. (e) Pattern #11. (f) Pattern #12. 
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(a)                                     (b) 
 
(c)                                     (d) 
 
(e)                                     (f)  
 
Fig. I-3.15: Six conformations of HIV-1 protease patterns with the top Z-score, in 
comparison with the crystal structure. Conformations of patterns are marked in pink 
and the crystal structure is in green. (a) Pattern #1. (b) Pattern #2. (c) Pattern #3. (d) 
Pattern #4. (e) Pattern #5. (f) Pattern #6. 
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(a)  
 
(b) 
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(c) 
 
(d) 
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(e)    
  
Fig. I-3.16: The residues with large binding energies of patterns #1 and #38 for HIV-1 
protease. (a) Pattern #1. Pro1, Gln2, Ile3, Leu5, Trp6, Leu24, Thr26, Gly27, Asp29, 
Arg87, Ile93, Cys95, Thr96, Leu97, Asn98, Phe99, Pro100, Gln101, Ile102, Leu104, 
Trp105, Arg107, Leu123, Asn124, Thr125, Arg186, Cys194, Thr195, Leu196, Asn197, 
Phe198 were labeled. (b) Pattern #38. Gln2, Ile3, Thr4, Leu5, Trp6, Gln7, Arg8, Pro9, 
Ile10, Leu23, Leu24, Ile66, Cys67, Thr96, Leu97, Asn98, Phe99, Gln101, Ile102, Leu104, 
Trp105, Gln106, Arg107, Pro108, Ile109, Leu122, Leu123, Ile192, Cys194, Leu196, 
Asn197, Phe198 were labeled. (c) The common residues for pattern #1. (d) The common 
residues for pattern #38. Ile3, Thr4, Leu5, Trp6, Leu24, Thr96, Leu97, Asn98, Phe99, 
Pro100, Gln101, Ile102, Leu104, Trp105, Arg107, Leu123, Cys194, Leu196, Asn197, 
Phe198 were labeled in (c) and (d). 
(e) The additional interaction for pattern #1. Pro81 and Ile149 were shown as sticks. 
5.0Å is the distance between two residues. 
 
 
 
 
Pro81     
 
          Ile149 
 48 
Table I-3.4: Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for HIV-1 protease. 
 
Orientation RMSD(Å) ZDock RMSD(Å) rmsd1) RMSD(Å) 
1 38 21.08  12) 1.66  1 1.66  
2 12) 1.66  2 5.01  3 2.21  
3 13 10.37  3 2.21  646 4.50  
4 4 7.12  4 7.12  8 4.67  
5 11 7.36  5 5.10  7 4.76  
6 12 5.97  6 34.17  2 5.01  
7 2 5.01  7 4.76  5 5.10  
8 8 4.67  8 4.67  25 5.61  
9 3 2.21  9 7.33  36 5.67  
10 510 25.67  10 5.87  16 5.84  
11 9 7.33  11 7.36  10 5.87  
12 282 6.64  12 5.97  12 5.97  
13 10 5.87  13 10.37  84 6.08  
14 213 23.35  14 33.03  282 6.64  
15 55 26.01  15 34.60  4 7.12  
16 255 39.75  16 5.84  65 7.13  
17 121 11.53  17 21.83  91 7.29  
18 608 39.72  18 14.12  9 7.33  
19 5 5.10  19 35.56  11 7.36  
20 631 14.89  20 30.11  69 7.99  
1) rmsd means the order based on RMSD. 
2) The pattern with the lowest RMSD is indicated by red. 
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I-3.1.5 HIV-1 reverse transcriptase 
The crystal structure of HIV-1 reverse transcriptase is shown in Fig. I-3.17(a).18 The 
total number of residues is the largest among the complexes in this study. There are 552 
residues in the p66 domain and 423 residues in the p51 domain. The large receptor and 
ligand gives a variety of form complex patterns compared with other complexes 
Fig. I-3.17(b) illustrates the Orientation score and Z-score for 960 patterns. Patterns 
#86, #82, #13, #46, #189 and #756 were selected as the top six patterns based on 
Orientation score. The structures of 6 patterns in the order of Orientation score and 6 
patterns from Z-score are shown in Fig. I-3.18(a-f) and Fig. I-3.19, respectively. The 
RMSD value between the crystal structure and the top 20 patterns selected based on 
Orientation and Z-scores are shown in Table I-3.5. 
All the RMSDs of 6 patterns with top Orientation scores exceed over 10Å. The 
pattern #93 is ranking 9th in the order of Orientation score, and its structure is the 
closest to the crystal structure (Fig. 18(g)). Because the pattern with the lowest RMSD 
is still in the top ten of the Orientation score, the result is regarded as an acceptable 
result.  
In the Z-score, the RMSD of pattern #4 is less than 10 Å, but the pattern with the 
lowest RMSD is ranking 93rd in the order of Z-score. Hence, the result of the 
Orientation score is reliable than the result of Z-score. 
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(a) 
 
(b) 
 
Fig. I-3.17: (a) Crystal structures of HIV-1 reverse transcriptase heterodimer. p66 
domain is green and p51 domain is pink. (b) x-axis means 960 conformations, and y-axes 
indicates the values of scores. The scale on the right side is about Orientation score and 
the values are represented by green line. The scale on the left side is about Z-score and 
the values are represented by pink line. Six patterns with top Orientation scores are 
labeled with pattern number.  
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(a)                                     (b) 
      
(c)                                     (d) 
      
(e)                                     (f)  
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(g) 
 
Fig. I-3.18: Six conformations of HIV-1 reverse transcriptase heterodimer with the top 
Orientation score, in comparison with the crystal structure. Conformations of patterns 
are marked in pink and the crystal structure is in green. (a) Pattern #86. (b) Pattern 
#82. (c) Pattern #13. (d) Pattern #46. (e) Pattern #189. (f) Pattern #756.(g) Pattern 
#93(9th in the order of Orientation score). 
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(a)                                     (b) 
 
(c)                                     (d) 
 
(e)                                     (f)  
 
Fig. I-3.19: Six conformations of HIV-1 reverse transcriptase heterodimer with the top 
Z-score, in comparison with the crystal structure. Conformations of patterns are 
marked in pink and the crystal structure is in green. (a) Pattern #1. (b) Pattern #2. (c) 
Pattern #3. (d) Pattern #4. (e) Pattern #5. (f) Pattern #6. 
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Table I-3.5: Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for HIV-1 reverse transcriptase heterodimer. 
 
Orientation RMSD(Å) ZDock RMSD(Å) rmsd1) RMSD(Å) 
1 86 31.71  1 53.76  93 5.66  
2 82 45.37  2 40.02  23 6.09  
3 13 22.09  3 38.97  101 7.83  
4 46 34.68  4 9.72  92 8.25  
5 189 49.11  5 52.08  64 9.20  
6 756 30.24  6 49.43  4 9.72  
7 24 45.68  7 48.62  8 9.88  
8 602 66.40  8 9.88  956 11.76  
9 932) 5.66  9 38.51  224 12.09  
10 28 34.15  10 36.99  152 13.81  
11 169 42.88  11 34.87  504 14.01  
12 550 39.37  12 67.83  105 14.67  
13 42 36.39  13 22.09  926 15.45  
14 424 71.22  14 38.59  772 16.06  
15 373 37.99  15 37.93  168 16.55  
16 852 31.24  16 39.04  124 16.80  
17 157 30.28  17 50.37  143 18.08  
18 423 35.54  18 38.41  661 18.71  
19 475 45.78  19 52.17  302 18.93  
20 43 29.55  20 50.49  500 18.94  
1) rmsd means the order based on RMSD. 
2) The pattern with the lowest RMSD is indicated by red. 
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I-3.1.6 Fab domain 
The crystal structure of the Fab complex is shown in Fig. I-3.20(a).19 Fab domain is 
different from other receptors in the study, because its structure of ligand is incomplete. 
In the Fab domain, the binding site is known, as a complementarity-determining region. 
The part of the ligand is part of HA protein. The secondary structure of the binding site 
is mainly loop.  
Fig. I-3.20(b) illustrates the Orientation score and Z-score for 960 patterns. Patterns 
#876, #35, #900, #502, #13 and #924 were selected as the top six patterns based on 
Orientation score. The structures of 6 patterns in the order of Orientation score and 6 
patterns from Z-score are shown in Fig. I-3.21 and Fig. I-3.22, respectively. The RMSD 
value between the crystal structure and top 20 patterns selected based on Orientation 
and Z-scores are shown in Table I-3.6. 
Both the Orientation score and Z-score cannot find the correct pattern. In both 
Orientation score and Z-scores within the top 6 patterns, all the RMSDs exceed over 
10Å. The pattern #430 with the closest conformation to crystal structure is ranking 
504th in the order of Orientation score, and ranking 430th in the order of Z-score. 
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(a) 
 
(b) 
 
Fig. I-3.20: (a) Crystal structure of Fab complex. Fab domain is green and HA protein is 
pink. (b) x-axis means 960 conformations, and y-axes indicates the values of scores. The 
scale on the right side is about Orientation score and the values are represented by 
green line. The scale on the left side is about Z-score and the values are represented by 
pink line. Six patterns with top Orientation scores are labeled with pattern number. 
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(a)                                     (b) 
                
(c)                                     (d) 
                
(e)                                     (f)  
                
Fig. I-3.21: Six conformations of Fab complex with the top Orientation score, in 
comparison with the crystal structure. Conformations of patterns are marked in pink 
and the crystal structure is in green. (a) Pattern #876. (b) Pattern #35. (c) Pattern #900. 
(d) Pattern #502. (e) Pattern #13. (f) Pattern #924. 
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(a)                                     (b) 
             
(c)                                     (d) 
              
(e)                                     (f)  
             
Fig. I-3.22: Six conformations of Fab complex with the top Z-score, in comparison with 
the crystal structure. Conformations of patterns are marked in pink and the crystal 
structure is in green. (a) Pattern #1. (b) Pattern #2. (c) Pattern #3. (d) Pattern #4. (e) 
Pattern #5. (f) Pattern #6. 
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Table I-3.6: Ranking of conformations, based on Orientation score, ZDock score, and 
RMSD for Fab domain. 
  Orientation RMSD(Å) ZDock RMSD(Å) rmsd1) RMSD(Å) 
1 878 52.96  1 27.17  430 3.82  
2 35 36.37  2 27.22  861 5.13  
3 900 53.68  3 29.55  452 7.40  
4 502 50.52  4 34.29  618 8.04  
5 13 42.61  5 54.69  435 10.34  
6 924 42.78  6 34.93  433 13.63  
7 523 40.76  7 26.45  212 14.58  
8 9 18.35  8 24.18  167 15.26  
9 179 52.15  9 18.35  50 15.60  
10 352 44.60  10 38.12  513 16.08  
11 749 49.71  11 28.92  533 16.16  
12 177 35.69  12 25.50  690 17.19  
13 239 49.54  13 42.61  865 17.55  
14 146 43.85  14 32.36  9 18.35  
15 413 46.59  15 27.83  364 18.87  
16 47 38.80  16 54.20  806 19.05  
17 38 29.23  17 48.22  23 19.15  
18 210 46.31  18 24.57  656 19.31  
19 524 51.48  19 47.24  123 20.10  
20 833 38.81  20 52.65  105 20.32  
 1) rmsd means the order based on RMSD. 
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I-3.2 Adjusting score based on the secondary structure 
Although prediction results for 4 protein complexes were sucessful as shown in 
section I-3.1, an adjustment of the Orientation score is expected to make prediction with 
more accurate. 
Concerning six types of protein complexes, the results of MMP-1, HIV-1 integrase 
and HIV-1 protease are better than those of others. In these complexes, the pattern with 
the closest to the crystal structure ranked in the top 3 based on the Orientation score. 
The reason is that only single secondaary structure exit at the binding site of ligand for 
MMP-1, HIV-1 integrase, and HIV-1 protease. In MMP-1, the secondary structure of 
ligand is special kind of helix named collagen helix, which consists of three peptide 
chains. In HIV-1 integrase, DNAs also keep double-helical structure. In HIV-1 protease 
homodimer, all the secondary structures of interfaces are loops. Hence, the single 
secondary structures were observed in the complexes that showed highly accurate 
prediction. 
In the process of calculation by Orientation, the step closely related to the secondary 
structure is structural geometry optimization to find the energy-minimized binding 
structure. To simplify the analysis, the secondary structure was classified into one of the 
α-helix (containing DNAs), β-sheet, and other (loop). The classification of secondary 
structure was performed by PyMOL. HLA was selected as an example. Fig. I-3.23 shows 
the classification of HLA protein complexes based on the secondary structure. The 
average RMSD of HLA 960 patterns between the conformations before and after 
geometry optimization was calculated. The averaged RMSD is 0.199Å for α-helixes, 
0.194Å for β-sheets and 0.213Å for loops. This suggests that structural changes of loops 
is high the energy gain by geometry optimization. Geometry optimization makes the 
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contact domains fit each other and gives a high Orientation score. Hence to reduce the 
effect of secondary structure, the modification of computed scores based on the 
secondary structure is necessary. Since the computational minimum unit is an atom, 
binding energy on every atom was summed for every residue. Based on the 
classification of secondary structure, the Orientation score was also devided into 
helix-score, sheet-score, and loop-score. While the value of helix-score and sheet-score 
remained, loop-score was reduced by multiplying a fixed factor value. To determine an 
adequate factor value, the different factor value 1.0, 0.9, 0.8, 0.7, 0.6 and 0.5 was tried. 
(Table I-3.7).  
In Table I-3.7, a pattern whose conformations are the closest to the crystal structure 
is labeled in bold. When the factor value is adjusted from 0.8 to 0.5, pattern #70 in 
MMP-1 complex ranks 3 instead of 2 based on the modified Orientation score. In the 
HIV-1 integrase complex, the ranking of pattern #171 rises from 2 to 1, when factor 
value is from 0.9 to 0.5. In the HLA complex, the ranking of pattern #1 rises from 5 to 4, 
when factor value is modified to 0.8 and 0.7. In the HIV-1 protease homodimer, the 
ranking of pattern #1 dropped, when the factor value is 0.6 and 0.5. In the HIV-1 
reverse transcriptase heterodimer, the ranking of pattern #93 is from 9 to 8, when factor 
value is 0.8 and 0.7. In the Fab domain complex, the pattern with the most similar 
conformation to the crystal structure does not exist in the top 10, regardless of the factor 
value.  
According to the results of 6 protein complexes, when the factor value is 0.9, its 
effect is too little to change the rankings of most protein complexes. On the other hand, 
the interfaces of some protein complexes are constituted mainly by loops, e.g. HIV-1 
protease homodimer. When the factor value is 0.5 and 0.6, the loop-score decreased and 
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was deviated from the correct result.  
At last, 0.7 was choice from the factor values 0.7 and 0.8. Except for HIV-1 protease 
homodimer, the sums of helix-score and sheet-score of patterns with the closest to the 
crystal structure generally improve the ranking compared to the other patterns showing 
good Orientation scores, but the situation of loop-score is opposite. Since the factor 
value, 0.7 and 0.8 have the same effect, the value 0.7 was selected. 
 
. 
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Fig. I-3.23: The classification of secondary structure for HLA protein complex. 
Secondary structure α-helix, β-sheet and loop are colored in red, yellow and green.
 6
4
 
Table I-3.7(a): Ranking of conformations, based on modified Orientation score with per factor values for MMP-1 
  1.0 RMSD(Å) 0.9 RMSD(Å) 0.8 RMSD(Å) 0.7 RMSD(Å) 0.6 RMSD(Å) 0.5 RMSD(Å) 
1 89 61.28  89 61.28  89 61.28  89 61.28  89 61.28  89 61.28  
2 4 5.33  4 5.33  70 3.52  70 3.52  70 3.52  70 3.52  
3 70 3.52  70 3.52  4 5.33  4 5.33  4 5.33  4 5.33  
4 758 8.80  758 8.80  758 8.80  758 8.80  758 8.80  78 61.57  
5 7 6.27  7 6.27  7 6.27  7 6.27  78 61.57  758 8.80  
6 78 61.57  78 61.57  78 61.57  78 61.57  7 6.27  7 6.27  
7 23 6.09  23 6.09  23 6.09  23 6.09  23 6.09  23 6.09  
8 121 63.66  121 63.66  121 63.66  121 63.66  121 63.66  121 63.66  
9 100 34.16  100 34.16  497 5.30  497 5.30  426 29.09  426 29.09  
10 497 5.30  497 5.30  100 34.16  426 29.09  497 5.30  497 5.30  
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Table I-3.7(b): Ranking of conformations, based on modified Orientation score with per factor values for HIV-1 integrase 
  1.0 RMSD(Å) 0.9 RMSD(Å) 0.8 RMSD(Å) 0.7 RMSD(Å) 0.6 RMSD(Å) 0.5 RMSD(Å) 
1 278 45.26  171 2.11  171 2.11  171 2.11  171 2.11  171 2.11  
2 171 2.11  278 45.26  278 45.26  822 28.41  822 28.41  822 28.41  
3 874 18.56  874 18.56  874 18.56  874 18.56  874 18.56  874 18.56  
4 54 27.59  54 27.59  822 28.41  278 45.26  54 27.59  54 27.59  
5 822 28.41  822 28.41  54 27.59  54 27.59  278 45.26  278 45.26  
6 299 48.42  299 48.42  299 48.42  299 48.42  299 48.42  299 48.42  
7 634 49.02  634 49.02  634 49.02  634 49.02  634 49.02  605 48.75  
8 193 44.95  193 44.95  193 44.95  193 44.95  193 44.95  634 49.02  
9 882 24.67  882 24.67  882 24.67  605 48.75  605 48.75  193 44.95  
10 843 26.04  843 26.04  843 26.04  882 24.67  843 26.04  843 26.04  
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Table I-3.7(c): Ranking of conformations, based on modified Orientation score with per factor values for HLA 
  1.0 RMSD(Å) 0.9 RMSD(Å) 0.8 RMSD(Å) 0.7 RMSD(Å) 0.6 RMSD(Å) 0.5 RMSD(Å) 
1 39 6.903  39 6.903  39 6.903  39 6.903  39 6.903  39 6.903  
2 605 12.845  605 12.845  605 12.845  605 12.845  605 12.845  605 12.845  
3 446 22.255  446 22.255  446 22.255  446 22.255  446 22.255  14 57.513  
4 640 37.570  640 37.570  1 2.196  1 2.196  14 57.513  446 22.255  
5 1 2.196  1 2.196  640 37.570  640 37.570  1 2.196  1 2.196  
6 416 25.327  117 9.585  117 9.585  14 57.513  8 11.897  8 11.897  
7 117 9.585  416 25.327  8 11.897  8 11.897  640 37.570  117 9.585  
8 434 8.826  434 8.826  434 8.826  117 9.585  117 9.585  640 37.570  
9 8 11.897  8 11.897  416 25.327  434 8.826  434 8.826  434 8.826  
10 67 12.599  67 12.599  67 12.599  416 25.327  67 12.599  370 41.618  
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Table I-3.7(d): Ranking of conformations, based on modified Orientation score with per factor values for HIV-1 protease 
  1.0 RMSD(Å) 0.9 RMSD(Å) 0.8 RMSD(Å) 0.7 RMSD(Å) 0.6 RMSD(Å) 0.5 RMSD(Å) 
1 38 21.09  38 21.09  38 21.09  38 21.09  38 21.09  38 21.09  
2 1 1.66  1 1.66  1 1.66  1 1.66  13 10.37  213 23.35  
3 13 10.37  13 10.37  13 10.37  13 10.37  1 1.66  13 10.37  
4 4 7.12  4 7.12  4 7.12  213 23.35  213 23.35  1 1.66  
5 11 7.36  11 7.36  11 7.36  4 7.12  4 7.12  4 7.12  
6 12 5.97  12 5.97  2 5.01  11 7.36  2 5.01  2 5.01  
7 2 5.01  2 5.01  12 5.97  2 5.01  11 7.36  11 7.36  
8 8 4.67  8 4.67  213 23.35  12 5.97  12 5.97  12 5.97  
9 3 2.21  510 25.68  510 25.68  510 25.68  510 25.68  510 25.68  
10 510 25.68  3 2.21  9 7.33  9 7.33  55 26.01  55 26.01  
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Table I-3.7(e): Ranking of conformations, based on modified Orientation score with per factor values for HIV-1 reverse transcriptase 
  1.0 RMSD(Å) 0.9 RMSD(Å) 0.8 RMSD(Å) 0.7 RMSD(Å) 0.6 RMSD(Å) 0.5 RMSD(Å) 
1 86 31.71  86 31.71  86 31.71  86 31.71  86 31.71  86 31.71  
2 82 45.37  82 45.37  82 45.37  82 45.37  82 45.37  82 45.37  
3 13 22.09  13 22.09  13 22.09  13 22.09  756 30.25  756 30.25  
4 46 34.68  756 30.25  756 30.25  756 30.25  13 22.09  13 22.09  
5 189 49.11  46 34.68  46 34.68  46 34.68  46 34.68  46 34.68  
6 756 30.25  189 49.11  189 49.11  189 49.11  189 49.11  189 49.11  
7 24 45.68  24 45.68  24 45.68  28 34.16  28 34.16  373 37.99  
8 602 66.41  602 66.41  93 5.67  93 5.67  373 37.99  28 34.16  
9 93 5.67  93 5.67  28 34.16  24 45.68  93 5.67  424 71.23  
10 28 34.16  28 34.16  602 66.41  424 71.23  424 71.23  93 5.67  
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Table I-3.7(f): Ranking of conformations, based on modified Orientation score with per factor values for Fab domain 
  1.0 RMSD(Å) 0.9 RMSD(Å) 0.8 RMSD(Å) 0.7 RMSD(Å) 0.6 RMSD(Å) 0.5 RMSD(Å) 
1 878 52.96  878 52.96  878 52.96  878 52.96  878 52.96  35 36.37  
2 35 36.37  35 36.37  35 36.37  35 36.37  35 36.37  878 52.96  
3 900 53.68  900 53.68  13 42.61  13 42.61  13 42.61  13 42.61  
4 502 50.52  13 42.61  900 53.68  900 53.68  900 53.68  523 40.76  
5 13 42.61  502 50.52  502 50.52  523 40.76  523 40.76  900 53.68  
6 924 42.78  924 42.78  924 42.78  502 50.52  502 50.52  48 42.82  
7 523 40.76  523 40.76  523 40.76  924 42.78  179 52.15  179 52.15  
8 9 18.35  179 52.15  179 52.15  179 52.15  924 42.78  38 29.23  
9 179 52.15  9 18.35  177 35.69  48 42.82  48 42.82  502 50.52  
10 352 44.60  177 35.69  146 43.85  38 29.23  38 29.23  924 42.78  
In the table, the pattern numbers with the lowest RMSD aming 960 patterns are labeled in bold. The pattern numbers are marked 
in blue when the ranking remains the same. Red indicates that the ranking is higher than initial one. If the ranking is lower than initial 
one, the pattern numbers are colored green. 
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I-4. Discussion 
I-4.1 Reducing Orientation calculation  
Orientation enables geometry optimization, which requires much calculation time 
compared with ZDock. Optimization using Orientation was performed with 
supercomputer at the University of Tokyo 
(http://www.issp.u-tokyo.ac.jp/supercom/home/). Calculation for 192 complex 
conformations can be executed in parallel, and 5 times parallel computation were 
preformed for one kind of protein. It sums is 960, and the whole process finished within 
one week. 2000 docking conformations were generated by ZDock, but only 960 
conformations were scored by Orientation. Although only the 960 generated 
conformations were re-scored, the part contained a conformation similar to the crystal 
structure (RMSD<5Å).  
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I-4.2 Water molecules  
Model solvation with water molecules is necessary for Orientation to calculate 
affinity scores, because hydrogen bonds are not only between two adjacent residues. 
There is one water molecule mediated hydrogen bond between ligand and receptor. On 
the other hand, if too many water molecules are included in the calculation model, such 
as a boundary box of TIP3PBOX water usually employed in molecular dynamics 
simulation like Amber16, it will take much time for geometry optimization.27 For 
example, MMP-1 needed 1797 water molecules to be wrapped with 2Å-width layer in 
the approach used in this paper. In contrast, TIP3PBOX a boundary box with water of to 
2Å-width generated 10977 water molecules (Fig. I-4-1). The width means the shortest 
distance from an atom of the protein complex to the boundary edge. Considering the 
accuracy of calculation and cost of time, the approach using a thin layer of water 
molecules to wrap the protein complex was adopted.  
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(a) 
 
(b) 
 
Fig. I-4.1: MMP-1 complexe with water molecules. (a) A approach of adding water 
molecules in this study. (b) An approach of adding water molecules using a boundary 
box. The arrows represent 2Å. 
 73 
I-4.3 Morse potential  
In the intra-molecular potential of Orientation scores, Morse potential was used 
instead of Lennard-Jones potential. In Lennard-Jones potential, there are 2 
parameters. 
       
  
 
 
  
   
  
 
 
 
   
  represents the depth of the potential well, re the equilibrated distance. The above 
equation is popular 12-6 LJ potential function and that is adopted in the calculation of 
van der Waals potential energies in AMBER force field.28, 29 
        
  
 
 
 
   
  
 
 
 
  
called 9-6 LJ potential function, that is applied to the calculation of van der Waals 
potential energies in COMPASS force field (Fig. I-4-2a).29, 30 Due to only 2 parameters, 
LJ potential cannot perfectly represent the energy curvature of the interaction between 
two atoms. 
To improve the problem, Morse potential was selected. 
             
              
De represents the depth of the potential well, re the equilibrated distance, an 
adjustable curvature. Comparing to LJ potential, the Morse potential can adjust the 
potential in detail through changing curvature, when the depth of the potential well and 
equilibrated distance have been determined. Fig. I-4.2(b) shows the contrast of 
curvature between Morse potential and LJ potential. When the potential well and 
equilibrated distance are given, the curvature of the potential energy is determined in 
12-6 LJ potential. However, the curvature is not determined in the case of Morse 
potential. 
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 (a) 
 
(b)  
 
Fig. I-4.2: Potential curve relative to the distance of two atoms in interaction. 
Horizontal axis is internuclear separation, and vertical axis is energy. The re means the 
equilibrium bond distance, and De is the depth of the potential well. (a) 12-6 LJ 
potential (red) and 9-6 LJ potential (green). (b) Comparison of Morse potential with 
different curvature and 12-6 LJ potential. When in Morse potential a is 0.14, 0.17, 0.20 
0.23 and 0.26, the color of line is pink, green, blue, purple and cyan. The curve of 12-6 
LJ potential is vermilion. 
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I-4.4 Optimizations of Orientation 
Rigid-rigid docking was performed by ZDock, and the docking sometimes made the 
atomic clashes between receptor and ligand (Fig. I-4.3(a)). The clashes are not fatal 
error for the experience-based program like ZDock, but it is crucial in the force 
field-based programs. The too-close distance between two atoms case abnormally high 
repulsive force, and it disturbs the evaluation to select the correct pattern. Moreover, 
referencing the evaluation standard of Critical Assessment of PRediction of Interactions 
(CAPRI), if there are clashes in the conformation of the protein complex, it will be 
removed in the first round. Hence, eliminating clashes is necessary. Fig. I-4.3(b) shows 
Orientation accomplished the purpose. Comparing to Fig. I-4.3(a), atoms were kept 
within the adequate distance in Fig. I-4.3(b). 
Another purpose of optimizations is to place the atoms at a suitable distance. For 
example, the crystal structure of HIV-1 reverse transcriptase without optimization was 
also calculated by Orientation. Though there are no clashes in the crystal structure, the 
Orientation score is 293.35 and ranking the last of the order of the Orientation score. 
However, the Orientation score of the crystal structure with optimization is -874.86 and 
ranking the first of the order of the Orientation score. 
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(a) 
 
(b) 
 
Fig. I-4.3: Comparing the conformation of HIV-1 reverse transcriptase pattern #93 
before and after optimizations. (a) Conformation before optimizations. In the circled 
part, residues are crossed. (b) Conformation after optimizations. In the circled part, 
residues are separated.  
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I-4.5 About the result of HIV-1 reverse transcriptase 
In the result of HIV-1 reverse transcriptase, the pattern #93 with the closest to 
the crystal structure is ranking 9th in the order of Orientation score. It is not so ideal 
and this section will explain the reason. 
The RMSD of ligands between pattern #93 and the crystal structure is 5.66Å. 
Referencing the evaluation standard of CAPRI, when the RMSD is higher than 5Å 
and less than 10Å, the pattern is regarded as an acceptable prediction. However, in 
the other 5 complexes, the RMSD of the pattern with the closest to the crystal 
structure is higher than 1Å and less than 5Å, and it is regarded as the medium 
prediction. From Fig. I-4.4, the right side of the ligand of pattern #93 is obviously 
deviated from the crystal structure, and compared to the crystal structure, the right 
part of the p51 domain of pattern #93 is moved away from p66 domain. It makes the 
Orientation score to be lower. 
For reference, the Orientation score of the crystal structure was calculated. The 
Orientation score of the crystal structure (-874.86) is better than pattern #86 (-749.92) 
with the top Orientation score. It means if there is a pattern with low RMSD to the 
crystal structure exist among 960 patterns, it can be found by Orientation with the 
best Orientation score.  
The residues with large binding energy in the crystal structure and pattern #93 
were examined. There are 37 residues with large binding energy in pattern #93, and 
63 residues in the crystal structure (Fig. I-4.5). Moreover, the 29 among 37 residues in 
pattern #93 are also shown as the strong binding energy in the crystal structure. 
The number of the labeled residues in the left of pattern #93 (26) is similar to the 
number  of those in the crystal structure (33), but the number of the labeled residues 
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in the right of pattern #93 (11) is lower obviously than the number of the crystal 
structure(30). The number in brackets is sum of residues shown in Table I-4.1. 
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                     Left                        Right 
 
Fig. I-4.4: Conformations of pattern #93 of HIV-1 reverse transcriptase, in comparison 
with the crystal structure. Conformations of pattern #93 are marked in pink and the 
crystal structure is in green. The circled helix is as boundary, and the structure is 
divided as left side and right side. 
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(a) 
 
(b) 
 
Fig. I-4.5: The residues with large binding energies of crystal structure and pattern #93 
for HIV-1 reverse transcriptase. p66 domain is green and p51 domain is pink. (a) 
Crystal structure. The residues with large binding energies were labeled in blue (b) 
Pattern #93. 
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Table I-4.1: The labeled residues with large binding energy in the crystal structure and 
pattern #93. 
 Left Right 
Receptor of 
crystal 
structure 
Lys9, Gln83, Asp84, Trp86, Lys99, 
Tyr179, Glu368, Gln371, Ile378, 
Trp400, Glu402, Tyr403, Trp404, 
Gln405, Ala406, Thr407, Trp408 
Lys429, Glu430, Gly434, Ala435, 
Thr437, Tyr439, Asn458, Gln498, 
Leu501, Gln505, Tyr530, Trp533, 
Val534, Lys538, Ile540 
Ligand of 
crystal 
structure 
Lys567, Glu575, Pro599, Glu600, 
Lys673, Asn683, Asn684, Glu685, 
Asp911, Val912, Pro939, Gln941, 
Glu943, Trp948, Val964, Pro967, 
Gln805, Lys806, Asn812, Val823, 
Leu830, Thr833, Lys834, Ala835, 
Leu836, Thr837, Lys878, Gln881,  
Leu969, Lys971, Trp973 
Receptor of 
pattern #93 
Asp84, Trp86, Lys99, Lys164, 
Glu167, Gln371, Val379, Trp381, 
Lys383, Trp404, Gln405, Ala406, 
Trp408 
Gln498, Gln505, Lys538, Ile540 
Ligand of 
pattern #93 
Lys567, Glu575, Glu600, Asn683, 
Asn684, Glu685, Lys971, Asp911, 
Pro939, Gln941, Glu943, Thr944, 
Trp948 
Gln805, Val808, Ser827, Leu830, 
Lys834, Leu836, Lys878 
Residues presented in both crystal structure and pattern #93 are labeled with red 
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I-4.6 About CDR of Fab domain 
Complementarity-determining regions (CDRs) are the variable parts in the Fab 
domain, where CDRs are connected to their specific antigen. In other words, when the 
Fab domain is bound to HA protein, the binding energy is concentrated on the CDR. 
Moreover, CDRs can be identification for every antibody. 31 Hence, based on the sum of 
the binding score of CDRs only, 960 patterns were ranked again. 
Arg23-Ala35 is L1, Gly52-Pro58 is L2, Ala91-Val99 is L3, Gly236-Hie245 is H1, 
Val260-Ser275 is H2, and Asp308-Tyr321 is H3 (Fig. I-4.6). The sums of the energy score 
of residues belonging to CDRs were calculated (Table I-4.2).  
In the new ranking of the Orientation score of CDRs, original pattern #876, #900, 
#502 and #13 with large RMSD were excluded from the new ranking. Pattern #9 which 
RMSD is 18.35Å is ranking 2nd in the order of the Orientation score of CDRs. The 
ranking of pattern #430 with the lowest RMSD rises from 504th to 286th. However, this 
is still an unsatisfactory result. 
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Fig. I-4.6: Crystal structure of Fab domain. L1 and H1 are labeled with pink. L2 and H2 
are labeled with cyan. L3 and H3 are labeled with yellow. 
 
 
 
 
 
 
 
 
 
 
 
L3              H3    H1 
   L1                              H2 
L2 
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Table I-4.2: Ranking of conformations, based on Orientation score of CDRs for Fab 
domain. 
order 
Pattern 
number 
H1 H2 H3 L1 L2 L3 sum  
RMSD 
(Å) 
1  35 -14.82  -24.12  -36.18  -9.53  0.00  -18.78  -103.43  36.37  
2  9 -8.96  -23.24  -46.70  -4.40  -0.33  -15.08  -98.70  18.35  
3  524 -3.73  -17.19  -42.95  -13.51  0.00  -16.96  -94.34  51.48  
4  38 -11.05  -30.42  -34.79  -4.75  0.00  -11.62  -92.63  29.23  
5  924 -14.91  -15.37  -40.89  -0.05  -17.34  -2.88  -91.45  42.78  
6  771 -17.81  -10.32  -46.20  -13.44  0.00  -2.89  -90.65  31.13  
7  14 -12.56  -13.65  -50.60  0.00  -10.26  -2.70  -89.78  32.36  
8  210 -6.94  -12.36  -32.24  -26.37  -3.62  -7.02  -88.56  46.31  
9  413 -11.78  -8.47  -36.26  -17.38  0.00  -14.17  -88.06  46.59  
10  523 -0.71  -17.48  -25.97  -14.22  -23.63  -5.97  -87.98  40.76  
11  177 -10.84  -6.44  -42.18  -16.03  -0.09  -11.25  -86.83  35.69  
12  179 -1.72  -8.42  -31.63  -36.73  -0.21  -7.78  -86.48  52.15  
13  317 -0.39  -19.96  -28.36  -18.47  -0.03  -18.59  -85.80  47.67  
14  653 -7.50  -16.29  -33.57  -16.34  0.00  -11.88  -85.58  43.19  
15  204 -5.56  -24.31  -33.20  -10.63  0.00  -10.02  -83.73  48.52  
     
. 
    
     
. 
.     
286  430 -10.93  -4.44  -37.86  -0.02  -1.20  -3.03  -57.48  3.82  
                                         . 
                                         . 
                                         . 
 
 
 
 
 
 
 85 
I-4.7 About the result of Fab domain 
Compared to the other five protein complexes, the result of the Fab domain is 
unsatisfactory. Though the result was modified with two approaches, the result is not 
still improved obviously. Hence, we analyze this problem from a structural perspective. 
The ligand of the Fab complex is the part of the human influenza A virus. In fact, it 
does not exist singly. The ligand HA1, is bound to HA2 and forms homotrimer (Fig. 
I-4.7(a)). There are many residues with large binding energy to hold the other polymer 
of HA1 or HA2. 
Pattern #35 was selected to analyze because it is ranking 2nd in the order of 
Orientation score, and 1st in the order of Orientation score of CDRs. The residues with 
large binding energy were marked in Fig. I-4.7(b), and the same residues are labeled in 
HA protein (Fig. I-4.7(a)). The site of the labeled residues in HA protein is the binding 
site to HA2 and other HA1s. Hence, the site with large binding energies is selected by 
Orientation. However, the site is impossible to hold the Fab domain, because it will 
bounds the other part of HA preferentially rather than the Fab domain, and it cannot 
form the conformation like pattern #35. 
 Hence, when the complete HA protein is adopted as the ligand, the result of 
prediction will be improved. 
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(a) 
 
(b)   
 
Fig. I-4.7: Comparing the residues with large binding energies in HA protein and Fab 
domain. (a) the crystal structure of HA (PDB code: 5K9Q).32 One of HA1 is labeled with 
pink, one of HA2 is labeled with cyan, and other parts of HA is in yellow. (b) HA1 is 
labeled in pink, and Fab domain is in green. The residues with large binding energies 
are labeled in blue. 
 
HA1 
 
 
 
 
 
 
 
 
 
 
 
 
HA2 
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I-5. CONCLUSION 
The prediction of complex conformation was applied to the crystal structure MMP-1, 
HIV-1 integrase, HLA, HIV-1 protease, HIV-1 reverse transcriptase, and Fab domain 
downloaded from PDB. In 960 patterns of MMP-1, the pattern with the closest 
conformation is ranking 3rd in the order of Orientation score. In HIV-1 integrase, it is 
ranking 2nd. In HLA, HIV-1 protease, and HIV-1 reverse transcriptase, they are 
ranking 5th, 2nd and 9th, respectively.  
The Orientation score was modified. When the secondary structure of residues is 
loop, its Orientation score was multiplied by 0.7. Based on the modified Orientation 
score, the pattern with the closest conformation moved up to ranking 2nd for MMP-1. In 
HIV-1 integrase, HLA, HIV-1 protease and HIV-1 reverse transcriptase, they are 
ranking 1st, 4th, 2nd and 8th, respectively. 
Because 4 complexes in the study were predicted accurately and because the problem 
in the other two is the generation of binding patterns by ZDock or in the fragmentation 
of proteins in crystallization, Orientation is reliable to predict complex structure. 
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Chapter II 
 
 
Computational Study on the Assembly of Amyloid 
β-Peptides in the Hydrophobic Environment 
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II-Abstract 
Fibrillated aggregation of amyloid β (Aβ) peptides is a potential factor causing toxic 
amyloid deposition in neurodegenerative diseases. A toxic fibril formation of Aβ is 
known to be enhanced on the ganglioside-rich lipid membrane containing some amounts 
of cholesterol and sphingomyelin. This ganglioside-rich membrane is supposed to 
provide a hydrophobic environment that promotes the formation of Aβ fibrils. Molecular 
dynamics simulations were carried out to investigate the structure of Aβ complex in the 
hydrophobic solution composed of dioxane and water molecules. The Aβ conformation 
was contrasted to that in the aqueous condition by executing multiple computational 
trials with the calculation models containing one, four, or six Aβ peptides. The 
simulations for Aβ42 demonstrated that Aβ peptides had a tendency to stretch out in the 
hydrophobic environment. In contrast, Aβ peptides were closely packed in the aqueous 
solution, and the motions of Aβ peptides were suppressed significantly. The N-terminal 
polar domains of Aβ peptides tended to be positioned at the inside of the Aβ complex in 
the hydrophobic environment, which supported the C-terminal domains in expanding 
outward for inter-molecular interaction. Since Aβ peptides were not tightly packed in 
the hydrophobic environment, the total surface area of the Aβ complex in the 
hydrophobic solution was larger than that in the aqueous one.  
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II-1. Introduction 
Amyloid β (Aβ) peptide is known as a major constituent of senile plaques in the 
brains of patients of Alzheimer’s disease (AD).33 The Aβ polymerization into fibrils has 
been broadly investigated because it is a critical step in the pathological process of the 
neurodegenerative disorders like AD.34 It has been suggested that, in the case of the 
absence of membrane, Aβ peptides develop into fibrils through a nucleation 
polymerization pathway that is characterized by an initial monomer-dominant phase, 
followed by a conformational shift to a β-sheet and an assembly of monomers into 
oligomers.35 In this pathway, oligomers are nuclei for the fibril aggregation, and the 
nuclei elongate through monomer addition to the growing polymers according to the 
so-called nucleation and growth process.36 In an experiment, the Aβ nucleation was 
observed at high Aβ concentrations in the range of 17.5 – 100 μM, while the 
physiological concentration of Aβ in the human brain is considered to be in the sub-nM 
level.37 Namely, the Aβ concentration is lower than the value set in the in vitro 
experiment without membrane by several orders. This means that the Aβ fibrillation 
will follow an alternative mechanism in vivo. Several studies have suggested a 
template-assisted mechanism to lower the energy barrier for the Aβ nucleation.38 In the 
mechanism, the cell membrane containing GM1 ganglioside provides a unique local 
environment and works as a catalyst for fibril formation.39 Indeed, the presence of 
GM1-containing neuronal cell membranes facilitated the polymerization of Aβ42 at 
nanomolar concentrations.40 
In the outer leaflet of a cell membrane, GM1 gangliosides compose clusters with 
including sphingomyelin (SM) and cholesterol (Chol) at high concentrations.41 This 
cluster is one of the major components of a particular kind of microdomain that has 
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been identified as a detergent-insoluble glycosphingolipid-rich component in the 
membrane of brain cells.42 GM1 ganglioside is abundant in the particular microdomain. 
The enhancement of Aβ binding to the cell membrane and the acceleration of the 
subsequent fibril formation were observed on the GM1 ganglioside containing 
microdomain.43 The concentrations of GM1 ganglioside and Chol are critical factors in 
the Aβ aggregation on the GM1 ganglioside-containing membrane and have strong 
influences on the fibrillation rate.44  
The amyloid fibrils formed on the cell membrane are cytotoxic, while those formed 
in aqueous solution are not.45 Hence, the presence of GM1 ganglioside will be 
significantly important for the aggregation of toxic Aβ fibrils. Based on the assumption 
that low-polarity environment provided by GM1 clusters promotes the formation of toxic 
Aβ fibrils, Fukunaga et al. investigated the structures of Aβ aggregates in solutions 
with several different polarities by mixing 1,4-dioxane into water.46 They found that a 
mixture of 80% dioxane and 20% water gave the polarity similar to the membrane 
surface, and the morphology, secondary structure, and cytotoxicity of the Aβ fibrils 
formed on this mixed solution were close to those of the toxic Aβ one.  
To grasp the growth process of the toxic Aβ fibrillation, simulation analysis should 
be performed on the structural transfer from the Aβ gathering into the Aβ nucleus that 
will develop into the toxic amyloid fibrils. In this work, we carried out long-time 
molecular dynamics (MD) simulations using the calculation models including one, four, 
or six Aβ peptides in the hydrophobic environment composed of the mixture of 
1,4-dioxane and water. For reference, MD simulations were also carried out in the 
aqueous condition. The structures of the Aβ aggregates were monitored through the 
simulations. Clarifying the molecular mechanism of the embryonic stage of Aβ fibril will 
 92 
be significantly important for designing an inhibitor that blocks the Aβ fibrillation or 
the deposition of Aβ plaque. 
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II-2. Methods 
II-2.1 Construction of calculation models 
One, four, and six Aβ1-42 peptides were separately placed in a rectangular box filled 
with 1,4-dioxane and water molecules in a ratio of 4:1 as models for the low-polarity 
solution. For comparison, one, four, and six Aβ peptides were also separately placed in a 
box solvated with water. The initial positions of Aβs were manually set to make the 
closest atom distance between any two Aβ molecules more than 5.0 Å. Sodium and 
chloride ions were also contained in the model to make the ion concentration equal to 
150 mM. The final model size was ca. 92 Å×92 Å×93 Å, and the total number of atoms 
was about 80,000 for every Aβ model. The initial atom coordinates of Aβ1-42 were 
extracted from a protein data bank (PDB)-deposited structure: 1Z0Q, which had been 
determined by solution nuclear magnetic resonance (NMR) spectroscopy.47 The 
structure 1Z0Q contains 30 conformations, and the 11th one was selected for the initial 
coordinates of Aβ for a reason described elsewhere.48 
II-2.2 Computational condition for MD simulation 
Minimization, heating, and pre-equilibration were executed using the sander 
module of AMBER16.49 The production run of MD simulation was carried out using the 
pmemd module. Energy minimization was achieved in two steps. The first step was 
subject to relaxation of the Aβ molecules only. The second step was for relaxation of the 
whole system. In each step, energy minimization was done for 10,000 cycles. The 
minimization method was switched from the steepest descent method to the conjugate 
gradient method after 3,000 cycles. The model system was heated to 310 K for 0.1 ns 
under the NVT-ensemble condition, and subsequent 0.4 ns pre-equilibrating calculation 
was executed under the NPT-ensemble condition. Then production runs of MD 
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simulation were carried out for 1 μs. Only for the six Aβs models, the simulation was 
extended to 5μs. The cutoff distance for the electrostatic and van der Waals energy 
terms was set to 12.0 Å, and the periodic boundary condition was applied. The particle 
mesh Ewald method was employed to calculate the long-distance electrostatic force. The 
expansion and shrinkage of every covalent bond connecting to a hydrogen atom were 
constrained. The integration time step was 2 fs.  
The ff14SB force field was applied to the protein molecules, while the general 
AMBER force field 2 (GAFF2) was to 1,4-dioxane. The atom charges of 1,4-dioxane were 
determined by the approach making use of the quantum chemical calculation.50-53 The 
stable structure of 1,4-dioxane was initially determined through geometry optimization 
at the B3LYP/6-31G(d,p) level, and the electrostatic potential was subsequently 
calculated at the B3LYP/cc-pVTZ level. The atom changes were calculated from the 
electrostatic potential.  
II-2.3 Analysis of simulation results 
The ptraj module of AmberTools16 was utilized to obtain snapshot structures from 
the simulation trajectory. The snapshot structures were depicted by PyMOL.26, 50 For a 
better understanding of simulation structures, the positions of some Aβ molecules were 
transferred along x, y, or z-direction by the side length of the periodic boundary box. 
Cluster analysis on the conformational diversity of Aβ42 was performed in a manner 
similar to our previous work.54 The coordinates of main-chain atoms were extracted 
every 0.1 μs from the trajectory of the last 1 μs for the six Aβs models. The average 
structure of the extracted structures was obtained. Then each extracted structure was 
fitted to the average one to calculate the root-mean-square deviation (RMSD). Based on 
the RMSD values, the structures were classified by performing cluster analysis with the 
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nearest neighboring method. Finally, all of the structures were connected as a tree 
called a dendrogram, in which the x-axis is the labels for the snapshot structures and 
the y-axis is the distance for the least dissimilarity among the individual structures. 
Based on the dendrogram, the snapshot structures were separated into several groups 
with setting the criteria distance to 15Å. 
The secondary structure of Aβ peptides was calculated using the DSSP program.55 
To monitor the change in secondary structure during simulation, the coordinates of 
main-chain atoms were extracted every 0.1 μs from the 5 μs trajectories of the six Aβs 
models. 
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II-3. Results 
II-3.1 Conformations of Aβ42 peptides in the low-polarity solution 
Fig. II-3.1 shows the final structures of the 1 μs MD simulation for one, four, and 
six Aβ42 peptides in the mixed solution of dioxane and water. Simulation structures of 
Aβ42 peptides in the aqueous solution are also shown for comparison. As for the single 
Aβ model, the peptide was unfolded in the mixed solution (Fig. II-3.1(a)). The secondary 
structure of the peptide was mainly coil except for one small helix. The polar N-terminal 
domain of Aβ was positioned inside, and the apolar C-terminal domain was located 
outside. Aβ peptide was slightly unfolded in the aqueous solution, and the β-sheet 
structure was formed at the middle of the peptide (Fig. II-3.1(a’)). No clear difference 
was observed between the N-terminal and C-terminal domains.  
The final structures of the 1 μs simulations for four Aβ peptides also suggest that 
the folding of Aβ is significantly loosened in the mixed solution (Fig. II-3.1(b)). All the 
Aβs were loosely assembled to make a single bunch of peptides. The apolar C-terminal 
domains of the peptides were likely to be positioned outside of the bunch. In contrast, 
four Aβs tightly gathered in the aqueous solution (Fig. II-3.1(b’)). The C-terminal 
hydrophobic regions were positioned at the middle of the peptide complex. All the four 
Aβs had a short helix, and those helices were located outside of the peptide complex. 
The difference in peptide conformation between the mixed and aqueous solutions 
was more distinctly observed in the six Aβs models (Fig. II-3.1(c)). In the mixed solution, 
the folding was loose for every Aβ, while six Aβs were assembled to be a single complex. 
The C-terminal apolar domains were positioned outside, and the N-terminal polar 
domains were inside. The secondary structure of the C-terminal domain was the coil, 
and then domains were likely to stretch outward. In contrast, the secondary structure of 
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the N-terminal domain was the helix, and the domains were folded compactly. In the 
aqueous solution, six Aβs gathered and were tightly packed (Fig. II-3.1(c’)). The helix 
regions were mostly located outside, and three long helices were observed in the outer 
area of the peptide assembly.  
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Fig. II-3.1: Structures of Aβ42 peptides at the final point of the 1 μs MD simulation. (a) 
One Aβ model in the mixed solution of dioxane and water. Aβ is depicted by a green 
cartoon in the upper figure, and by a graduation color from blue to red with N- to 
C-terminal side in the lower one. (a’) Single Aβ model in water. (b) Four Aβs model in the 
mixed solution. Aβs are colored green, cyan, magenta, and yellow in the upper and 
middle figures. The respective Aβs are depicted by graduation color in the lower one. (b’) 
Four Aβs model in the aqueous environment. (c) Six Aβs model in the mixed solution. 
Aβs are colored in green, cyan, magenta, yellow, orange, and purple in the upper and 
middle figures and in graduation in the lower one. (c’) Six Aβs model in the aqueous 
solution. 
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II-3.2 Extended simulation of six Aβ42 peptides 
MD simulations for six Aβs models were extended to 5 μs both for the mixed and 
aqueous solutions. The final snapshot structures are illustrated with different colors 
among the Aβs and also a gradation of color from N- to C-terminus for every Aβ (Fig. 
II-3.2(a-a’)). The structure of Aβ complex in the mixed solution was almost consistent 
with that of the 1 μs simulation in Fig. II-3.1(c). The C-terminal domains of Aβ peptides 
were positioned outside and spread in the mixed solution. In contrast, the N-terminal 
polar domains were located on the inside of the Aβ assembly. In the aqueous solution, 
Aβs were tightly packed, and most of the helix regions tended to gather and kept stable 
interactions among them. 
The structure change of the Aβ assembly over time is shown in Fig. II-3.3 and II-3.4  
for the mixed solution and Fig. II-3.5 and II-3.6 for the aqueous one. The six Aβs in the 
mixed solution were not in a completely single cluster at 0.5 μs (Fig. II-3.3(a)). All the 
Aβs gathered at 1.0 μs (Fig. II-3.3(b)), and the structure of the Aβs complex was not 
largely changed until 2.0 μs (Fig. II3.3(c-d)). The C-terminal domains were positioned 
outside as seen in Fig. II-3.4(b-d). A few Aβs were converted into an expanded form after 
2.5 μs (Fig. II-3.3(e)), and most of the expanded regions were C-terminal domains (Fig. 
II-3.4e). The C-terminal domains were further expanded after 3.0 μs (Fig. II-3.3(f-h)), 
and it was clearly observed in Fig. II-3.4h that the C-terminal domains stretched while 
the N-terminal domains were compact inside. The expanded C-terminal domains 
sometimes changed their conformations to the β-bridge after 4.0 μs (Fig. II-3.3(i-j)). Fig. 
II-3.4(h-j) demonstrated that the C-terminal apolar domains were located outside, and 
the N-terminal polar domains were inside. In contrast to the mixed solution, the 
structure of the Aβs complex was not drastically altered for 5.0 μs in the aqueous 
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solution. All the Aβs gathered to be one cluster at 0.5 μs (Fig. II-3.5(a)). The complex 
structure and the relative positions of the Aβ molecules were hardly altered for 5.0 μs 
(Fig. II-3.5(b-j)). The C-terminal hydrophobic domains were not always located outside, 
while the N-terminal polar domains were frequently exposed to solvent (Fig. II-3.6(a-j)). 
Since the MD simulations were performed under the periodic boundary condition, 
the expanded C-terminal domain reaches the boundary edge and possibly interacts with 
the Aβ peptides of the adjacent calculation cell. Fig. II-3.2(b) is an illustration of two Aβ 
complex in two adjacent calculation cells of the simulation in the mixed solution, in 
which the Aβ assembly of the adjacent cell was generated by copying the Aβs of the 
original cell and shifting their coordinates by the length of one unit cell. An expanded 
C-terminal domain was found to form a parallel β-sheet with the C-terminal domain of 
another Aβ in the adjacent cell. This β-sheet formation was so stable that it was 
maintained for the last 2.0 μs of the simulation.  
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Fig. II-3.2: Structures of six Aβ42 peptides after the 5 μs simulations. (a, a’) Six Aβs in 
the mixed solution (a) and in water (a’). See the caption of Fig. II-3.1 for colors. (b) 
Illustration of two Aβ bundles in the two adjacent periodic calculation cells of the 
simulation in the mixed solution. Aβs are depicted in different colors at the left figure 
and are in graduation color at the right one. 
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Fig. II-3.3.: Conformational changes of six Aβ1-42 peptides during the 5 μs simulation in 
the mixed solution of dioxane and water. Snapshot structures were acquired every 0.5μs 
and superimposed on the initial one. Aβ peptides were colored green, cyan, magenta, 
yellow, orange, and purple. 
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Fig. II-3.4: Conformational changes of six Aβ1-42 peptides during the 5 μs MD simulation 
in the mixed solution of dioxane and water. The coloring of Aβs was modified from Fig. 
II-3.3 such that residue colors were gradually changed from blue to red with N- to 
C-terminal side for the respective peptides. 
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Fig. II-3.5: Conformational changes of six Aβ1-42 peptides during the 5 μs simulation in 
the water. Snapshot structures were acquired every 0.5μs and superimposed on the 
initial one. Six Aβ peptides were colored green, cyan, magenta, yellow, orange, and 
purple. 
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Fig. II-3.6: Conformational changes of six Aβ1-42 peptides during the 5 μs MD simulation 
in the water. The coloring of six Aβs was modified from Fig. II-3.5 such that residue 
colors were gradually changed from blue to red with N- to C-terminal side for the 
respective peptides. 
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II-3.3 Surface area of the Aβ complex and inter-molecular hydrogen bonding 
Fig. II-3.7(a) shows the change in total surface area of the Aβ complex for 5 μs MD 
simulations with six peptide models in the mixed and aqueous solutions. The Aβ 
complex in the mixed solution has larger surface areas than those in the aqueous 
solution. These results mean that the Aβ42 peptides in the mixed solution are most 
loosely packed among the two models. The loose packing is advantageous for converting 
the conformations of Aβ peptides. In every model, the surface area tends to decrease 
over time. Hence, it is expected that the structure of Aβ complex further alters if the 
simulation time is extended more. 
The changes in the total number of inter-molecular hydrogen bonds summed up for 
all the combinations of every two Aβs are shown in Fig. II-3.7(b). The total number of 
hydrogen bonds in the aqueous solution is larger than that in the mixed solution. This 
result is compatible with the findings that the Aβ complex in the aqueous solution is 
more tightly packed compared to that in the mixed solution. The number of 
inter-molecular hydrogen bonds of every Aβ peptide was also monitored along the 
simulation (Fig. II-3.8). The numbers ceaselessly vary during the simulation, which 
implies the possibility that the structure of the Aβ complex is converted if the 
simulation time is extended much more. The number of Aβ peptide pairs that have 
hydrogen bond interactions is shown in Fig. II-3.7(c). The total number of the Aβs 
combinations is 15 for six peptides model. About half of the combinations have hydrogen 
bonds for Aβ42 in the mixed solution, while more than two-thirds of the combinations 
have hydrogen bonds in the aqueous solution. This result reflects the situation that the 
Aβ complex is loosely packed in the mixed solution. 
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Fig. II-3.7: Time course of changes in surface area, hydrogen bond, and hydrogen bond 
interaction. (a) Change in total surface area calculated for a complex of six Aβ peptides 
during the 5 μs simulations. The surface areas in the simulations with the mixed 
solution and water are thick red and thin blue lines, respectively. (b) Change in the total 
number of inter-molecular hydrogen bonds for a complex of six Aβ peptides during the 5 
μs simulations. The coloring is the same as (a). (c) Number of Aβ peptide pairs that have 
hydrogen bonding interactions. The combination of Aβ pairs is 15 for a complex of six Aβ 
peptides. Hence, the number indicates 15 when every Aβ molecule interacts with every 
other Aβ molecule. 
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Fig. II-3.8: Changes in the number of inter-molecular hydrogen bonds that every Aβ 
peptide formed in the 5 μs simulation. (a, b) Six Aβ42 peptides in the mixed (a) and 
aqueous (b) solution. Colors correspond to the drawings of Aβ peptides in Fig. II-3.1(c), 
and II-3.1(c’).  
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II-4. Discussion 
II-4.1 Secondary structure of Aβ peptides 
Aβ peptides aggregate into insoluble fibrils, which accumulate to be toxic plaques 
causing the neurodegeneration.56 According to a solution NMR study, Aβ peptides in the 
fibrils have the β-sheet conformation and are aligned to be a closely packed form.57 
Since the major secondary structure of the isolated Aβ is α-helix, the conformational 
conversion of Aβ peptide due to the interaction with other Aβs is expected. Hence, the 
change in secondary structure was examined for the respective residues of the Aβs 
through MD simulations (Fig. II-4.1, II-4.2). 47, 58 
As seen in Fig. II-4.1 and II-4.2, turn or bend was the major secondary structure of 
Aβ42 both in the mixed and aqueous solutions. In the mixed solution (Fig. II-4.1), the 
amount of helix was much larger than that of β-strand or β-bridge. The frequency of 
β-strand or β-bridge was slightly increased with the progress of MD simulations, and 
that of β-strand or β-bridge for two Aβs were almost comparable to the helix one (Fig. 
II-4.1(e-f)). In the aqueous solution (Fig. II-4.2), a small amount of β-strand or β-bridge 
constantly appeared, and except for that, no remarkable difference was observed 
between the mixed and aqueous solutions.  
The secondary structure was determined by the DSSP program, which doesn’t take 
the intermolecular interaction into account. Many intermolecular hydrogen bonds were 
observed among the Aβ42 peptides in the mixed solution, and most of the residues 
involving the intermolecular hydrogen bonds formed the turn or bend. The 
conformation of these residues is expected to be converted into the β-strand with the 
development into fibrils. 
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Fig. II-4.1: Frequencies of the secondary structures appearing in the 5 μs simulation for 
the Aβ42 peptides in the mixed solution. Numbers of residues forming helix, β-strand or 
β-bridge, and turn or bend structures are denoted by red, blue, and green, respectively. 
(a)-(f) correspond to one of the six Aβs colored differently in Fig. II-3.3. 
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Fig. II-4.2: Frequencies of the secondary structures appearing in the 5 μs simulation for 
the Aβ42 peptides in the aqueous solution. Numbers of residues forming helix, β-strand 
or β-bridge, and turn or bend structures are denoted by red, blue, and green, 
respectively. (a)-(f) correspond to one of the six Aβs colored in differently Fig. II-3.5. 
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II-4.2 Structural diversity of Aβ peptides in simulation 
In the dendrogram obtained by the cluster analysis, the snapshot structures were 
separated into six major groups and two minor fractions for the last 1 μs of the 
simulation with six Aβ42 peptides in the mixed solution (Fig. II-4.3(a)). Every major 
group almost consisted of the snapshots of a specific one of the six Aβs. This indicated 
that the conformations of the respective Aβs were no longer largely changed for the last 
1 μs, and that the conversion of the Aβ conformation rarely occurred in the Aβ assembly. 
For the simulation of the aqueous solution, the snapshots of six Aβs were separated into 
seven groups (Fig. II-4.3(b)). One Aβ peptide labeled as b was split into two groups, in 
which the snapshots for 4.2 – 4.5 μs formed one cluster, and the snapshots for 4.6 – 5.0 
μs formed another. Hence, a noticeable conformational change appeared only for one Aβ 
for the 1 μs simulation time. 
The y-axis of the dendrogram indicates the dissimilarity of the snapshots. The 
dissimilarities among the group members in the mixed solution are, on the whole, larger 
than those in the aqueous solution. This means that the motions of Aβ42 peptides are 
restricted in the aqueous environment compared to the mixed solution. 
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Fig. II-4.3: Cluster analysis on the 60 snapshot structures of six Aβ42 peptides acquired 
every 0.1 μs for the last 1 μs. (a) Simulation in the mixed solution of dioxane and water. 
(b) Simulation in the water. The x-axis of the dendrogram is the label for snapshots, in 
which alphabet is identification of each Aβ peptide and numeral is time for snapshot. 
The y-axis is the distance for the least dissimilarity among the individual structures. 
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II-4.3 Comparison with the previous calculation studies 
The interaction of two Aβ42 peptides was examined by the MD simulations with 
several kinds of lipid membranes with different lipid components.59 The simulation 
showed that a part of the Aβ peptide was expanded on the lipid membrane, which is 
consistent with our present study. Aβ tetramer was initially built in the solution 
without membrane, and then the Aβ tetramer was placed on the membrane surface. A 
modulation in the structure of Aβ42 tetramer was observed, in which the Aβ42 tetramer 
was elongated in the presence of membrane, and the contact area among Aβ42 peptides 
was rearranged. The β-strand content was slightly increased on the raft-mimicking 
membrane model, and the C-terminal region of an Aβ peptide was loosened, which is 
consistent with our present simulation result.  
An MD simulation for short amyloid peptide (Aβ13-23) was performed, including the 
effect of the lipid membrane by making a mixture of water and cyclohexane as a 
calculation model.60 The β-sheet formation emerged during the simulation, while the 
helix content was diminished at the late stage of the 0.5 μs simulation. Although the 
short peptide can readily change its conformation, the β-sheet was stably formed in the 
simulation with the hydrophobic environment. 
The replica exchange molecular dynamics (REMD) simulation was adapted for Aβ42, 
and Met35-oxidized Aβ42.61 Anti-parallel β-hairpins were observed between 
Leu17-Ala21, Ala30-Leu36, and Val39-Ile41, which were expected to work as a seed for 
Aβ oligomer and fibril. The results intimated that the rate of the fibril formation would 
be low for Met35-oxidized Aβ42, compared to Aβ42. The prediction of the fibrillation rate 
is compatible with our present simulation.  
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An energy landscape for the Aβ fibrillation was suggested by a recent MD 
simulation study.62 An isolated monomer was in the disordered form with a short helix 
at the central hydrophobic core region (Leu17-Asp23). A hairpin structure, however, 
became stable in the oligomer because of the formation of hydrogen bonds between 
neighboring monomers. The prefibrillar oligomer mainly consisted of anti-parallel 
β-sheet, which would be converted into a fibrillar oligomer with parallel β-sheet. The 
energy change for this conversion was nearly downhill. In view of this energy landscape, 
the gathering of Aβ peptides shown in our present study is still at the initial stage of the 
fibrillation process, and the content of β-strand or β-bridge is still small. 
Most of the previous computational studies on the interaction of multiple Aβ 
peptides were performed in the aqueous solution. For example, MD simulations of Aβ42 
trimer and pentamer in water were reported for analyzing the stability of the 
inter-molecular contact.63 The trimer and pentamer were set to be in a hairpin shape 
with two β-sheet regions (residues 18-26 and 31-42), derived from an NMR structure 
(PDB#: 2BEG). The two β-sheet regions kept their conformations during the simulation 
in solution, while the residues 31-42 were more tightly bundled than the residues 18-26. 
This simulation suggested that the β-sheet structure of Aβ peptides was stable in the 
aqueous solution once the sheet formation was established. 
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II-5. Conclusion 
Multiple MD simulations were performed to examine the conformations of Aβ42 and 
Aβ40 peptides and their complex structure in the hydrophobic environment. The 
hydrophobicity was provided by a mixture of 80% dioxane and 20% water in the 
calculation model. One, four, or six Aβ peptides were placed in the mixed solution and 1 
μs simulations were performed for the respective models. For the six Aβs model, the 
simulations were extended to 5 μs. MD simulations were also performed in the aqueous 
solution without dioxane for comparison. It was demonstrated by the simulations that 
Aβ42 peptides gathered to be a single complex both in the mixed and aqueous solutions. 
In the mixed solution, the folding of the Aβ42 peptide was loose. The C-terminal 
hydrophobic domains were positioned outside of the Aβ complex and tended to spread 
outward. The N-terminal polar domains were positioned inside. In contrast, Aβ42 
peptides were tightly packed in the aqueous solution. In this simulation study, a 
markedly stable interaction was generated within 5 μs for Aβ42 peptides, in which two 
Aβs took a formation of the parallel β-sheet structure. The parallel β-sheet structure is 
expected to be a seed for the Aβ fibrils.  
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